¼ÓÈëVIP ÉÏ´«¿¼²©×ÊÁÏ ÄúµÄÁ÷Á¿ Ôö¼ÓÁ÷Á¿ ¿¼²©±¨°à ÿÈÕÇ©µ½
   
Ö÷Ìâ : ÖìÓñÏÍ·Ö×Ó±±´ó±Ê¼Ç
¼¶±ð: ³õ¼¶²©ÓÑ
ÏÔʾÓû§ÐÅÏ¢ 
Â¥Ö÷  ·¢±íÓÚ: 2009-09-08   

ÖìÓñÏÍ·Ö×Ó±±´ó±Ê¼Ç

ÏÖ´ú·Ö×ÓÉúÎïѧ±Ê¼Ç£¨ÖìÓñÏͰ棩 uJw?5kEbv<  
  µÚÒ»½² ÐòÂÛ Xs0)4U  
Er;/ zxg9p  
¶þ¡¢ÏÖ´ú·Ö×ÓÉúÎïѧÖеÄÖ÷ÒªÀï³Ì±® r9[S%Def  
·Ö×ÓÉúÎïѧÊÇÑо¿ºËËá¡¢µ°°×ÖʵÈËùÓÐÉúÎï´ó·Ö×ÓµÄÐÎ̬¡¢½á¹¹ÌØÕ÷¼°ÆäÖØÒªÐÔ¡¢¹æÂÉÐÔºÍÏ໥¹ØϵµÄ¿Æѧ£¬ÊÇÈËÀà´Ó·Ö×ÓˮƽÉÏÕæÕý½Ò¿ªÉúÎïÊÀ½çµÄ°ÂÃØ£¬Óɱ»¶¯µØÊÊÓ¦×ÔÈ»½çתÏòÖ÷¶¯µØ¸ÄÔìºÍÖØ×é×ÔÈ»½çµÄ»ù´¡Ñ§¿Æ¡£µ±ÈËÃÇÒâʶµ½Í¬Ò»ÉúÎﲻͬÊÀ´úÖ®¼äµÄÁ¬ÐøÐÔÊÇÓÉÉúÎïÌå×ÔÉíËùЯ´øµÄÒÅ´«ÎïÖÊËù¾ö¶¨µÄ£¬¿Æѧ¼ÒΪ½ÒʾÕâЩÒÅ´«ÃÜÂëËù½øÐеÄŬÁ¦¾Í³ÉΪÈËÀàÕ÷·þ×ÔÈ»µÄÒ»²¿·Ö£¬¶øÒÔÉúÎï´ó·Ö×ÓΪÑо¿¶ÔÏñµÄ·Ö×ÓÉúÎïѧ¾ÍѸËÙ³ÉΪÏÖ´úÉç»áÖÐ×î¾ß»îÁ¦µÄ¿Æѧ¡£ 2 XP }:e  
´Ó1847ÄêSchleidenºÍSchwannÌá³ö"ϸ°ûѧ˵"£¬Ö¤Ã÷¶¯¡¢Ö²ÎﶼÊÇÓÉϸ°û×é³ÉµÄµ½½ñÌ죬ËäÈ»²»¹ý¶Ì¶ÌÒ»°Ù¶àÄêʱ¼ä£¬ÎÒÃǶÔÉúÎï´ó·Ö×Ó--ϸ°ûµÄ»¯Ñ§×é³ÉÈ´ÓÐÁËÉî¿ÌµÄÈÏʶ¡£Ãϵ¶ûµÄÒÅ´«Ñ§¹æÂÉ×îÏÈʹÈËÃǶÔÐÔ×´ÒÅ´«²úÉúÁËÀíÐÔÈÏʶ£¬¶øMorganµÄ»ùÒòѧ˵Ôò½øÒ»²½½«"ÐÔ×´"Óë"»ùÒò"ÏàñîÁª£¬³ÉΪ·Ö×ÓÒÅ´«Ñ§µÄµì»ùʯ¡£WatsonºÍCrickËùÌá³öµÄÍÑÑõºËÌÇËáË«ÂÝÐýÄ£ÐÍ£¬Îª³ä·Ö½ÒʾÒÅ´«ÐÅÏ¢µÄ´«µÝ¹æÂÉÆÌƽÁ˵À·¡£ÔÚµ°°×ÖÊ»¯Ñ§·½Ã棬¼ÌSumnerÔÚ1936Äê֤ʵøÊǵ°°×ÖÊÖ®ºó£¬SangerÀûÓÃÖ½µçÓ¾¼°²ãÎö¼¼ÊõÓÚ1953ÄêÊ״βûÃ÷ÒȵºËصÄÒ»¼¶½á¹¹£¬¿ª´´Á˵°°×ÖÊÐòÁзÖÎöµÄÏȺӡ£¶øKendrewºÍPerutzÀûÓÃXÉäÏßÑÜÉä¼¼Êõ½âÎöÁ˼¡ºìµ°°×£¨myoglobin£©¼°Ñªºìµ°°×£¨hemoglobin£©µÄÈýά½á¹¹£¬ÂÛÖ¤ÁËÕâЩµ°°×ÖÊÔÚÊäËÍ·Ö×ÓÑõ¹ý³ÌÖеÄÌØÊâ×÷Ó㬳ÉΪÑо¿ÉúÎï´ó·Ö×Ó¿Õ¼äÁ¢Ìå¹¹Ð͵ÄÏÈÇý¡£ +fP.Ewi  
1910Ä꣬µÂ¹ú¿Æѧ¼ÒKosselµÚÒ»¸ö·ÖÀëÁËÏÙàÑßÊ£¬ÐØÏÙà×ऺÍ×é°±Ëá¡£ fVbjU1N  
1959Ä꣬ÃÀ¹ú¿Æѧ¼ÒUchoaµÚÒ»´ÎºÏ³ÉÁ˺ËÌǺËËᣬʵÏÖÁ˽«»ùÒòÄÚµÄÒÅ´«ÐÅϢͨ¹ýRNA·­Òë³Éµ°°×ÖʵĹý³Ì¡£Í¬Ä꣬KornbergʵÏÖÁËÊÔ¹ÜÄÚϸ¾úϸ°ûÖÐDNAµÄ¸´ÖÆ¡£ my (@~'  
1962Ä꣬Watson£¨ÃÀ£©ºÍCrick£¨Ó¢£©ÒòΪÔÚ1953ÄêÌá³öDNAµÄ·´ÏòƽÐÐË«ÂÝÐýÄ£ÐͶøÓëWilkins¹²»ñNobleÉúÀíҽѧ½±£¬ºóÕßͨ¹ýXÉäÏßÑÜÉä֤ʵÁËWatson-CrickÄ£ÐÍ¡£ m'rDoly"62  
1965Ä꣬·¨¹ú¿Æѧ¼ÒJacobºÍMonodÌá³ö²¢Ö¤ÊµÁ˲Ù×Ý×Ó£¨operon£©×÷Ϊµ÷½Úϸ¾úϸ°û´úлµÄ·Ö×Ó»úÖÆ¡£´ËÍ⣬ËûÃÇ»¹Ê×´ÎÍƲâ´æÔÚÒ»ÖÖÓëDNAÐòÁÐÏ໥²¹¡¢Äܽ«ËüËù±àÂëµÄÒÅ´«ÐÅÏ¢´øµ½µ°°×Öʺϳɳ¡Ëù£¨Ï¸°ûÖÊ£©²¢·­Òë²úÉúµ°°×ÖʵÄmRNA£¨ÐÅʹºËÌǺËËᣩ¡£ '`>%RZ]  
1972Ä꣬Paul Berg£¨ÃÀ£©µÚÒ»´Î½øÐÐÁËDNAÖØ×é¡£ 1m*)MZ)  
1977Ä꣬SangerºÍGilbert£¨Ó¢£©µÚÒ»´Î½øÐÐÁËDNAÐòÁзÖÎö¡£ W$4$%r8  
1988Ä꣬McClintockÓÉÓÚÔÚ50Äê´úÌá³ö²¢·¢ÏÖÁË¿ÉÒƶ¯ÒÅ´«Òò×Ó£¨jumping gene»ò³Æmobile element£©¶ø»ñµÃNobel½±¡£ 7(Fas(j3  
1993Ä꣬ÃÀ¹ú¿Æѧ¼ÒRobertsºÍSharpÒò·¢ÏÖ¶ÏÁÑ»ùÒò£¨introns£©¶ø»ñµÃNobel½±¡£MullisÓÉÓÚ·¢Ã÷PCRÒǶøÓë¼ÓÄôóѧÕßSmith£¨µÚÒ»¸öÉè¼Æ»ùÒò¶¨µãÍ»±ä£©¹²ÏíNobel»¯Ñ§½±¡£ L&pR#  
´ËÍ⣬Griffith£¨1928£©¼°Avery£¨1944£©µÈÈ˹ØÓÚÖ²¡Á¦Ç¿µÄ¹â»¬ÐÍ£¨SÐÍ£©·ÎÑ×Á´Çò¾úDNAµ¼ÖÂÖ²¡Á¦ÈõµÄ´Ö²ÚÐÍ£¨RÐÍ£©Ï¸¾ú·¢ÉúÒÅ´«×ª»¯µÄʵÑ飻HersheyºÍChase£¨1952£©¹ØÓÚDNAÊÇÒÅ´«ÎïÖʵÄʵÑ飻CrickÓÚ1954ÄêËùÌá³öµÄÒÅ´«ÐÅÏ¢´«µÝ¹æÂÉ£¨¼´ÖÐÐÄ·¨Ôò£©:MeselsonºÍStahl£¨1958£©¹ØÓÚDNA°ë±£Áô¸´ÖƵÄʵÑéÒÔ¼°YanofskyºÍBrener£¨1961£©Äê¹ØÓÚÒÅ´«ÃÜÂëÈýÁª×ÓµÄÉèÏ붼Ϊ·Ö×ÓÉúÎïѧµÄ·¢Õ¹×ö³öÁËÖØ´ó¹±Ïס£ `YNzcn0x  
ÎÒ¹úÉúÎï¿Æѧ¼ÒÎâÏÜ20ÊÀ¼Í20Äê´ú³õ»Ø¹úºóÔÚЭºÍÒ½¿Æ´óѧÉú»¯ÏµÓëÍôéà¡¢ÕŲýÓ±µÈÈËÒ»µÀÍê³ÉÁ˵°°×ÖʱäÐÔÀíÂÛ¡¢ÑªÒºÉú»¯¼ì²âºÍÃâÒß»¯Ñ§µÈһϵÁÐÓÐÖØ´óÓ°ÏìµÄÑо¿£¬³ÉΪÎÒ¹úÉúÎﻯѧ½çµÄÏÈÇý¡£20ÊÀ¼Í60Äê´ú¡¢70Äê´úºÍ80Äê´ú£¬ÎÒ¹ú¿Æѧ¼ÒÏà¼ÌʵÏÖÁËÈ˹¤È«ºÏ³ÉÓÐÉúÎïѧ»îÐԵĽᾧţÒȵºËØ£¬½â³öÁËÈý·½¶þпÖíÒȵºËصľ§Ìå½á¹¹£¬²ÉÓÃÓлúºÏ³ÉÓëø´ÙÏà½áºÏµÄ·½·¨Íê³ÉÁ˽Íĸ±û°±ËáתÒƺËÌǺËËáµÄÈ˹¤È«ºÏ³É£¬ÔÚøѧÑо¿¡¢µ°°×Öʽṹ¼°ÉúÎïĤ½á¹¹Ó빦Äܵȷ½Ã涼ÓÐÊÀËùÖõÄ¿µÄ½¨Ê÷¡£ 6G8No-#y  
nLN0zfhE#  
Èý¡¢·Ö×ÓÉúÎïѧµÄÖ÷ÒªÑо¿ÄÚÈÝ @{Rb]d?&F?  
ËùÓÐÉúÎïÌåÖеÄÓлú´ó·Ö×Ó¶¼ÊÇÒÔ̼ԭ×ÓΪºËÐÄ£¬²¢ÒÔ¹²¼Û¼üµÄÐÎʽÓëÇâ¡¢Ñõ¡¢µª¼°Á×ÒÔ²»Í¬·½Ê½¹¹³ÉµÄ¡£²»½öÈç´Ë£¬Ò»ÇÐÉúÎïÌåÖеĸ÷ÀàÓлú´ó·Ö×Ó¶¼ÊÇÓÉÍêÈ«ÏàͬµÄµ¥Ì壬Èçµ°°×ÖÊ·Ö×ÓÖеÄ20ÖÖ°±»ùËá¡¢DNA¼°RNAÖеÄ8ÖÖ¼î»ùËù×éºÏ¶ø³ÉµÄ£¬Óɴ˲úÉúÁË·Ö×ÓÉúÎïѧµÄ3Ìõ»ù±¾Ô­Àí£º :u>RyKu|&R  
1£® ¹¹³ÉÉúÎïÌåÓлú´ó·Ö×ӵĵ¥ÌåÔÚ²»Í¬ÉúÎïÖж¼ÊÇÏàͬµÄ£» `"5U b,~  
2£® ÉúÎïÌåÄÚÒ»ÇÐÓлú´ó·Ö×ӵĽ¨³É¶¼×ñѭן÷×ÔÌض¨µÄ¹æÔò£» +kL7"  
3£® ijһÌض¨ÉúÎïÌåËùÓµÓеĺËËá¼°µ°°×ÖÊ·Ö×Ó¾ö¶¨ÁËËüµÄÊôÐÔ¡£ TRhMxH  
·Ö×ÓÉúÎïѧÑо¿ÄÚÈÝ: sscbf  
DNAÖØ×é¼¼Êõ------»ùÒò¹¤³Ì Z& _kq|  
»ùÒò±í´ïµ÷¿Ø-------ºËËáÉúÎïѧ )+_Vx}O:}  
ÉúÎï´ó·Ö×ӽṹ¹¦ÄÜ----½á¹¹·Ö×ÓÉúÎïѧ wC1pfXa  
DNAÖØ×é¼¼Êõ£¨ÓֳƻùÒò¹¤³Ì£© Od!)MQ*,  
ÕâÊÇ20ÊÀ¼Í70Äê´ú³õÐËÆðµÄ¼¼Êõ¿Æѧ£¬Ä¿µÄÊǽ«²»Í¬DNAƬ¶Î£¨Èçij¸ö»ùÒò»ò»ùÒòµÄÒ»²¿·Ö£©°´ÕÕÈËÃǵÄÉè¼Æ¶¨ÏòÁ¬½ÓÆðÀ´£¬ÔÚÌض¨µÄÊÜÌåϸ°ûÖÐÓëÔØÌåͬʱ¸´ÖƲ¢µÃµ½±í´ï£¬²úÉúÓ°ÏìÊÜÌåϸ°ûµÄеÄÒÅ´«ÐÔ×´¡£ÑϸñµØ˵£¬DNAÖØ×é¼¼Êõ²¢²»ÍêÈ«µÈÓÚ»ùÒò¹¤³Ì£¬ÒòΪºóÕß»¹°üÀ¨ÆäËû¿ÉÄÜʹÉúÎïϸ°û»ùÒò×é½á¹¹µÃµ½¸ÄÔìµÄÌåϵ¡£DNAÖØ×é¼¼ÊõÊǺËËữѧ¡¢µ°°×ÖÊ»¯Ñ§¡¢Ã¸¹¤³Ì¼°Î¢ÉúÎïѧ¡¢ÒÅ´«Ñ§¡¢Ï¸°ûѧ³¤ÆÚÉîÈëÑо¿µÄ½á¾§£¬¶øÏÞÖÆÐÔÄÚÇÐøDNAÁ¬½Óø¼°ÆäËû¹¤¾ßøµÄ·¢ÏÖÓëÓ¦ÓÃÔòÊÇÕâÒ»¼¼ÊõµÃÒÔ½¨Á¢µÄ¹Ø¼ü¡£ C QkY6  
DNAÖØ×é¼¼ÊõÓÐ׏ãÀ«µÄÓ¦ÓÃÇ°¾°:DNAÖØ×é¼¼Êõ¿ÉÓÃÓÚ¶¨Ïò¸ÄÔìijЩÉúÎï»ùÒò×é½á¹¹£¬Ê¹ËüÃÇËù¾ß±¸µÄÌØÊâ¾­¼Ã¼ÛÖµ»ò¹¦ÄܵÃÒԳɰ٠ÉÏǧ±¶µÄµØÌá¸ß¡£DNAÖØ×é¼¼Êõ»¹±»ÓÃÀ´½øÐлù´¡Ñо¿¡£Èç¹û˵£¬·Ö×ÓÉúÎïѧÑо¿µÄºËÐÄÊÇÒÅ´«ÐÅÏ¢µÄ´«µÝºÍ¿ØÖÆ£¬ÄÇô¸ù¾ÝÖÐÐÄ·¨Ôò£¬ÎÒÃÇÒªÑо¿µÄ¾ÍÊÇ´ÓDNAµ½RNA£¬ÔÙµ½µ°°×ÖʵÄÈ«¹ý³Ì£¬Ò²¼´»ùÒòµÄ±í´ïÓëµ÷¿Ø¡£ÔÚÕâÀÎÞÂÛÊǶÔÆô¶¯×ÓµÄÑо¿£¨°üÀ¨µ÷¿ØÔª¼þ»ò³Æ˳ʽ×÷ÓÃÔª¼þ£©£¬»¹ÊǶÔת¼Òò×ӵĿË¡¼°·ÖÎö£¬¶¼Àë²»¿ªÖØ×éDNA¼¼ÊõµÄÓ¦Óᣠdbf<k%i6  
\c_g9Iqa  
»ùÒò±í´ïµ÷¿ØÑо¿ PmuG(qg  
ÒòΪµ°°×ÖÊ·Ö×Ó²ÎÓë²¢¿ØÖÆÁËϸ°ûµÄÒ»Çдúл»î¶¯£¬¶ø¾ö¶¨µ°°×ÖʽṹºÍºÏ³ÉʱÐòµÄÐÅÏ¢¶¼ÓɺËËᣨÖ÷ÒªÊÇÍÑÑõºËÌǺËËᣩ·Ö×Ó±àÂ룬±íÏÖΪÌض¨µÄºËÜÕËáÐòÁУ¬ËùÒÔ»ùÒò±í´ïʵÖÊÉϾÍÊÇÒÅ´«ÐÅÏ¢µÄת¼ºÍ·­Òë¡£ÔÚ¸öÌåÉú³¤·¢Óý¹ý³ÌÖÐÉúÎïÒÅ´«ÐÅÏ¢µÄ±í´ï°´Ò»¶¨µÄʱÐò·¢Éú±ä»¯£¨Ê±Ðòµ÷½Ú£©£¬²¢Ëæ×ÅÄÚÍâ»·¾³µÄ±ä»¯¶ø²»¶Ï¼ÓÒÔÐÞÕý£¨»·¾³µ÷¿Ø£©¡£ ~+Wx\:TT  
Ô­ºËÉúÎïµÄ»ùÒò×éºÍȾɫÌå½á¹¹¶¼±ÈÕæºËÉúÎï¼òµ¥£¬×ªÂ¼ºÍ·­ÒëÔÚͬһʱ¼äºÍ¿Õ¼äÄÚ·¢Éú£¬»ùÒò±í´ïµÄµ÷¿ØÖ÷Òª·¢ÉúÔÚת¼ˮƽ¡£ÕæºËÉúÎïÓÐϸ°ûºË½á¹¹£¬×ªÂ¼ºÍ·­Òë¹ý³ÌÔÚʱ¼äºÍ¿Õ¼äÉ϶¼±»·Ö¸ô¿ª£¬ÇÒÔÚת¼ºÍ·­Òëºó¶¼Óи´ÔÓµÄÐÅÏ¢¼Ó¹¤¹ý³Ì£¬Æä»ùÒò±í´ïµÄµ÷¿Ø¿ÉÒÔ·¢ÉúÔÚ¸÷ÖÖ²»Í¬µÄˮƽÉÏ¡£»ùÒò±í´ïµ÷¿ØÖ÷Òª±íÏÖÔÚÐźŴ«µ¼Ñо¿¡¢×ªÂ¼Òò×ÓÑо¿¼°RNA¼ô¼­3¸ö·½Ãæ¡£ q/s-".%P  
ת¼Òò×ÓÊÇһȺÄÜÓë»ùÒò5¡¯¶ËÉÏÓÎÌض¨ÐòÁÐרһ½áºÏ£¬´Ó¶ø±£Ö¤Ä¿µÄ»ùÒòÒÔÌض¨µÄÇ¿¶ÈÔÚÌض¨µÄʱ¼äÓë¿Õ¼ä±í´ïµÄµ°°×ÖÊ·Ö×Ó¡£ XZE(& (s  
ÕæºË»ùÒòÔڽṹÉϵIJ»Á¬ÐøÐÔÊǽü10ÄêÀ´ÉúÎïѧÉϵÄÖØ´ó·¢ÏÖÖ®Ò»¡£µ±»ùÒòת¼³Épre-mRNAºó£¬³ýÁËÔÚ5¡¯¶Ë¼Óñ¼°3¡¯¶Ë¼Ó¶à¾ÛA[polyA]Ö®Í⣬»¹Òª½«¸ô¿ª¸÷¸öÏàÁÚ±àÂëÇøµÄÄÚº¬×Ó¼ôÈ¥£¬Ê¹ÍâÏÔ×Ó£¨±àÂëÇø£©ÏàÁ¬ºó³ÉΪ³ÉÊìmRNA¡£Ñо¿·¢ÏÖ£¬ÓÐÐí¶à»ùÒò²»Êǽ«ËüÃǵÄÄÚº¬×ÓÈ«²¿¼ôÈ¥£¬¶øÊÇÔÚ²»Í¬µÄϸ°û»ò²»Í¬µÄ·¢Óý½×¶ÎÓÐÑ¡ÔñµØ¼ô½ÓÆäÖв¿·ÖÄÚº¬×Ó£¬Òò´ËÉú³É²»Í¬µÄmRNA¼°µ°°×ÖÊ·Ö×Ó¡£ LU6R"c11  
+( LH!\{^  
½á¹¹·Ö×ÓÉúÎïѧ &~:EmLgv  
ÉúÎï´ó·Ö×ӵĽṹ¹¦ÄÜÑо¿£¨Óֳƽṹ·Ö×ÓÉúÎïѧ£© Ò»¸öÉúÎï´ó·Ö×Ó£¬ÎÞÂÛÊǺËËá¡¢µ°°×ÖÊ»ò¶àÌÇ£¬ÔÚ·¢»ÓÉúÎïѧ¹¦ÄÜʱ£¬±ØÐë¾ß±¸Á½¸öÇ°Ìá:Ê×ÏÈ£¬ËüÓµÓÐÌض¨µÄ¿Õ¼ä½á¹¹£¨Èýά½á¹¹£©£»Æä´Î£¬ÔÚËü·¢»ÓÉúÎïѧ¹¦ÄܵĹý³ÌÖбض¨´æÔÚ׎ṹºÍ¹¹ÏóµÄ±ä»¯¡£ lp`j3)  
½á¹¹·Ö×ÓÉúÎïѧ¾ÍÊÇÑо¿ÉúÎï´ó·Ö×ÓÌض¨µÄ¿Õ¼ä½á¹¹¼°½á¹¹µÄÔ˶¯±ä»¯ÓëÆäÉúÎïѧ¹¦ÄܹØϵµÄ¿Æѧ¡£Ëü°üÀ¨½á¹¹µÄ²â¶¨¡¢½á¹¹Ô˶¯±ä»¯¹æÂɵÄ̽Ë÷¼°½á¹¹Ó빦ÄÜÏ໥¹ØϵµÄ½¨Á¢3¸öÖ÷ÒªÑо¿·½Ïò¡£×î³£¼ûµÄÑо¿Èýά½á¹¹¼°ÆäÔ˶¯¹æÂɵÄÊÖ¶ÎÊÇXÉäÏßÑÜÉäµÄ¾§Ìåѧ£¨ÓֳƵ°°×Öʾ§Ìåѧ£©£¬Æä´ÎÊÇÓöþάºË´Å¹²ÕñºÍ¶àάºË´ÅÑо¿ÒºÏà½á¹¹£¬Ò²ÓÐÈËÓõ羵ÈýάÖØ×é¡¢µç×ÓÑÜÉä¡¢ÖÐ×ÓÑÜÉäºÍ¸÷ÖÖƵÆ×ѧ·½·¨Ñо¿ÉúÎï¸ß·Ö×ӵĿռä½á¹¹¡£ )!8q JQD  
 /YJo"\7  
X!KX4H  
v5[gFY(?  
µÚ¶þ½² ȾɫÌåÓëDNA RY;V@\pRY+  
Ò»¡¢ DNAµÄ×é³ÉÓë½á¹¹ :8yebOs   
AveryÔÚ1944ÄêµÄÑо¿±¨¸æÖÐдµÀ£º"µ±ÈÜÒºÖоƾ«µÄÌå»ý´ïµ½9/10ʱ£¬ÓÐÏËά״ÎïÖÊÎö³ö¡£ÈçÉÔ¼Ó½Á°è£¬Ëü¾Í»áÏóÃÞÏßÔÚÏßÖáÉÏÒ»ÑùÈÆÔÚÓ²°ôÉÏ£¬ÈÜÒºÖеÄÆäËü³É·ÝÔò³Ê¿ÅÁ£×´³Áµí¡£ÈܽâÏËά״ÎïÖʲ¢Öظ´Êý´Î£¬¿ÉÌá¸ßÆä´¿¶È¡£ÕâÒ»ÎïÖʾßÓкÜÇ¿µÄÉúÎïѧ»îÐÔ£¬³õ²½ÊµÑé֤ʵ£¬ËüºÜ¿ÉÄܾÍÊÇDNA¡£¶ÔDNA·Ö×ÓµÄÎïÀí»¯Ñ§Ñо¿µ¼ÖÂÁËÏÖ´úÉúÎïѧ·­Ì츲µØµÄ¸ïÃü£¬Õâ¸üÊÇAveryËùûÓÐÏëµ½¡£ d"|_NG`vr  
ËùνDNAµÄÒ»¼¶½á¹¹£¬¾ÍÊÇÖ¸4ÖÖºËÜÕËáµÄÁ¬½Ó¼°ÆäÅÅÁÐ˳Ðò£¬±íʾÁ˸ÃDNA·Ö×ӵĻ¯Ñ§¹¹³É¡£ºËÜÕËáÐòÁжÔDNA¸ß¼¶½á¹¹µÄÐγÉÓкܴóÓ°Ï죬ÈçB-DNAÖжà¾Û£*****-C£©ÇøÒ׳öÏÖ×óÊÖÂÝÐýDNA£¨Z-DNA£©£¬¶ø·´ÏòÖظ´µÄDNAƬ¶ÎÒ׳öÏÖ·¢¿¨Ê½½á¹¹µÈ¡£DNA²»½ö¾ßÓÐÑϸñµÄ»¯Ñ§×é³É£¬»¹¾ßÓÐÌØÊâµÄ¸ß¼¶½á¹¹£¬ËüÖ÷ÒªÒÔÓйæÔòµÄË«ÂÝÐýÐÎʽ´æÔÚ£¬Æä»ù±¾ÌصãÊÇ£º x^lc T  
1¡¢DNA·Ö×ÓÊÇÓÉÁ½Ìõ»¥ÏàƽÐеÄÍÑÑõºËÜÕË᳤Á´ÅÌÈƶø³ÉµÄ¡£ -d ,D!  
2¡¢DNA·Ö×ÓÖеÄÍÑÑõºËÌǺÍÁ×Ëá½»ÌæÁ¬½Ó£¬ÅÅÔÚÍâ²à£¬¹¹³É»ù±¾¹Ç¼Ü£¬¼î»ùÅÅÁÐÔÚÄڲࡣ m` 1dB%;?  
3¡¢Á½ÌõÁ´Éϵļî»ùͨ¹ýÇâ¼üÏà½áºÏ£¬Ðγɼî»ù¶Ô£¬ËüµÄ×é³ÉÓÐÒ»¶¨µÄ¹æÂÉ¡£Õâ¾ÍÊÇàÑßÊÓëà×à¤Åä¶Ô£¬¶øÇÒÏÙàÑßÊ£¨A£©Ö»ÄÜÓëÐØÏÙà×ण¨T£©Åä¶Ô£¬ÄñàÑßÊ£*****£©Ö»ÄÜÓë°ûà×ण¨C£©Åä¶Ô¡£ÈçÒ»ÌõÁ´ÉÏijһ¼î»ùÊÇC£¬ÁíÒ»ÌõÁ´ÉÏÓëËüÅä¶ÔµÄ¼î»ù±Ø¶¨ÊÇG¡£¼î»ùÖ®¼äµÄÕâÖÖÒ»Ò»¶ÔÓ¦µÄ¹Øϵ½Ð¼î»ù»¥²¹Åä¶ÔÔ­Ôò¡£×é³ÉDNA·Ö×ӵļî»ùËäȻֻÓÐ4ÖÖ£¬ËüÃǵÄÅä¶Ô·½Ê½Ò²Ö»ÓÐAÓëT£¬CÓëGÁ½ÖÖ£¬µ«ÊÇ£¬ÓÉÓÚ¼î»ù¿ÉÒÔÈκÎ˳ÐòÅÅÁУ¬¹¹³ÉÁËDNA·Ö×ӵĶàÑùÐÔ¡£ÀýÈ磬ijDNA·Ö×ÓµÄÒ»Ìõ¶àºËÜÕËáÁ´ÓÐ100¸ö²»Í¬µÄ¼î»ù×é³É£¬ËüÃǵĿÉÄÜÅÅÁз½Ê½¾ÍÊÇ4100¡£ aO{@.  
bxa>:71  
¶þ¡¢ DNA¾ÛºÏøÓëDNAµÄºÏ³É d+DO }=]  
The accuracy of translation relies on the specificity of base pairing. The actual rate in bacteria seems to be --10-8-10-10. This corresponds to -1 error per genome per 1000 bacterial replication cycles, or -10-6 per gene per generation. tA1?8`bQ  
DNA polymerase might improve the specificity of complementary base selection at either (or both) of two stages: c7CYulm  
1£¬It could scrutinize the incoming base for the proper complementarity with the template base; for example, by specifically recongnizing matching chemical features. This would be a presynthetic error control. ^Gk)aX  
2£¬Or it could scrutinize the base pair after the new base has been added to the chain, and, in those cases in which a mistake has been made, remove the most recently added base. This would be a proofreading control. & AK\Pw)  
.@{v{  
Èý¡¢DNAµÄÉúÀíÒâÒå¼°³É·Ö·ÖÎö OU{c| O  
ÔçÔÚ1928ÄêÓ¢¹ú¿Æѧ¼ÒGriffithµÈÈ˾ͷ¢ÏÖ·ÎÑ×Á´Çò¾úʹСÊó²Ð·ÏµÄÔ­ÒòÊÇÒýÆð·ÎÑס£Ï¸¾úµÄ¶¾ÐÔ£¨Ö²¡Á¦£©ÊÇÓÉϸ°û±íÃæ¼ÔĤÖеĶàÌÇËù¾ö¶¨µÄ¡£¾ßÓй⻬Íâ±íµÄSÐÍ·ÎÑ×Á´Çò¾úÒòΪ´øÓмÔĤ¶àÌǶø¶¼ÄÜʹСÊó·¢²¡£¬¶ø¾ßÓдֲÚÍâ±íµÄRÐÍÒòΪûÓмÔĤ¶àÌǶøʧȥÖ²¡Á¦£¨¼ÔĤ¶àÌÇÄܱ£»¤Ï¸¾úÃâÊÜÔ˶¯°×ϸ°û¹¥»÷£©¡£ Bz'.7" ":0  
Ê×ÏÈÓÃʵÑéÖ¤Ã÷»ùÒò¾ÍÊÇDNA·Ö×ÓµÄÊÇÃÀ¹úÖøÃûµÄ΢ÉúÎïѧ¼ÒAvery¡£AveryµÈÈ˽«¹â»¬ÐÍÖ²¡¾ú£¨SÐÍ£©ÉÕÖóɱÃð»îÐÔÒÔºóÔÙÇÖȾСÊ󣬷¢ÏÖÕâЩËÀϸ¾ú×ÔȻɥʧÁËÖ²¡ÄÜÁ¦¡£ÔÙÓûîµÄ´Ö²ÚÐÍϸ¾ú£¨RÐÍ£©À´ÇÖȾСÊó£¬Ò²²»ÄÜʹ֮·¢²¡£¬ÒòΪ´Ö²ÚÐÍϸ¾úÌìÈ»ÎÞÖ²¡Á¦¡£µ±ËûÃǽ«¾­ÉÕÖóɱËÀµÄSÐÍϸ¾úºÍ»îµÄRÐÍϸ¾ú»ìºÏÔÙ¸ÐȾСÊóʱ£¬ÊµÑéСÊóÿ´Î¶¼ËÀÁË¡£½âÆÊËÀÊ󣬷¢ÏÖÓдóÁ¿»îµÄSÐÍ£¨¶ø²»ÊÇRÐÍ£©Ï¸¾ú¡£ËûÃÇÍƲ⣬ËÀϸ¾úÖеÄijһ³É·ÖÔæת»¯Ô´£¨transforming principle£©½«ÎÞÖ²¡Á¦µÄϸ¾úת»¯³É²¡Ô­Ï¸¾ú¡£ d/  Lz"  
ÃÀ¹úÀäȪ¸Û¿¨ÄÚ»ùÒÅ´«Ñ§ÊµÑéÊÒ¿Æѧ¼ÒHersheyºÍËûµÄѧÉúChaseÔÚ1952Äê´ÓÊÂÊɾúÌåÇÖȾϸ¾úµÄʵÑé¡£ÊɾúÌåרÃżÄÉúÔÚϸ¾úÌåÄÚ¡£ËüµÄÍ·¡¢Î²Íⲿ¶¼ÓÐÓɵ°°×ÖÊ×é³ÉµÄÍâ¿Ç£¬Í·ÄÚÖ÷ÒªÊÇDNA¡£ÊɾúÌåÇÖȾϸ¾úµÄ¹ý³Ì¿ÉÒÔ·ÖΪÒÔÏÂ5¸ö²½Ö裺¢ÙÊɾúÌåÓÃβ²¿µÄÄ©¶Ë£¨»ùƬ¡¢Î²Ë¿£©Îü¸½ÔÚϸ¾ú±íÃ棻¢ÚÊɾúÌåͨ¹ýβÖá°ÑDNAÈ«²¿×¢Èëϸ¾úϸ°ûÄÚ£¬ÊɾúÌåµÄµ°°×ÖÊÍâ¿ÇÔòÁôÔÚϸ°ûÍâÃ棻¢ÛÊɾúÌåµÄDNAÒ»µ©½øÈëϸ¾úÌåÄÚ£¬Ëü¾ÍÄÜÀûÓÃϸ¾úµÄÉúÃü¹ý³ÌºÏ³ÉÊɾúÌå×ÔÉíµÄDNAºÍµ°°×ÖÊ£»¢ÜкϳɵÄDNAºÍµ°°×ÖÊÍâ¿Ç£¬ÄÜ×é×°³ÉÐíÐí¶à¶àÓëÇ×´úÍêÈ«ÏàͬµÄ×ÓÊɾúÌ壻¢Ý×Ó´úÊɾúÌåÓÉÓÚϸ¾úµÄ½âÌå¶ø±»ÊͷųöÀ´£¬ÔÙÈ¥ÇÖȾÆäËûϸ¾ú¡£ËûÃÇ·¢ÏÖ±»¸ÐȾµÄϸ¾úÖдøÓÐ70%µÄÊɾúÌåDNA£¬µ«Ö»´øÓÐ20%µÄÊɾúÌåµ°°×ÖÊ¡£×Ó´úÊɾúÌåÖдøÓÐ50%±ê¼ÇµÄDNA£¬È´Ö»ÓÐ1%µÄ±ê¼Çµ°°×ÖÊ¡£ f0P,j~]  
ËÄ. C-valueºÍCot1/2  ?s,oH  
2/3yW.C  
`,AOxJ:$  
Îå¡¢ ȾɫÌå½á¹¹ >lIzeEW#  
ÈκÎÒ»ÌõȾɫÌåÉ϶¼´øÓÐÐí¶à»ùÒò£¬Ò»Ìõ¸ßµÈÉúÎïµÄȾɫÌåÉÏ¿ÉÄÜ´øÓгÉǧÉÏÍò¸ö»ùÒò£¬Ò»¸öϸ°ûÖеÄÈ«²¿»ùÒòÐòÁм°Æä¼ä¸ôÐòÁÐͳ³ÆΪgenomes£¨»ùÒò×飩¡£ Èç¹ûÉèÏ뽫ÈËÌåϸ°ûÖеÄDNA·Ö×ÓÈƵØÇòÒ»ÖÜ£¬ÄÇô£¬Ã¿¸ö¼î»ù´óÔ¼Ö»Õ¼1£­5ÀåÃ×£¬¶øÒ»¸ö2£­3kbµÄ»ùÒòÖ»Ï൱ÓÚµØÇòÉÏÒ»ÌõÊýÊ®Ã׳¤£¬ÊýÀåÃ׿íµÄÏ߶Σ¡ b36{vcs~  
1gK|n  
Genotype (»ùÒòÐÍ)£º The genetic constitution of a given organism (ָij¸öÌض¨ÉúÎïÌåϸ°ûÄÚµÄÈ«²¿ÒÅ´«ÎïÖÊ)¡£ !SuflGx,q  
Phenotype (±íÏÖÐÍ)£º Visible property of any given organism (ij¸öÌض¨ÉúÎïÌåÖпɹ۲쵽µÄÎïÀí»òÉúÀíÏÖÏó)¡£ 0[UI'2  
Mutations£º ȾɫÌåDNAÖпÉÒÅ´«µÄºËÜÕËáÐòÁб仯¡£ du$lS':`  
2S_u/32]W  
Áù¡¢ ȾɫÌåµÄ×é³É O.jm{x!m  
1£®È¾É«ÖʺͺËСÌå qt9jZtx  
ȾɫÖÊDNAµÄTmÖµ±È×ÔÓÉDNA¸ß£¬ËµÃ÷ÔÚȾɫÖÊÖÐDNA¼«¿ÉÄÜÓëµ°°×ÖÊ·Ö×ÓÏ໥×÷Óã»ÔÚȾɫÖÊ״̬Ï£¬ÓÉDNA¾ÛºÏøºÍRNA¾ÛºÏø´ß»¯µÄDNA¸´ÖƺÍת¼»îÐÔ´ó´óµÍÓÚÔÚ×ÔÓÉDNAÖеķ´Ó¦£»DNAøI£¨DNaseI£©¶ÔȾɫÖÊDNAµÄÏû»¯Ô¶Ô¶ÂýÓÚ¶Ô´¿DNAµÄ×÷Óá£È¾É«Öʵĵç×ÓÏÔ΢¾µÍ¼ÏÔʾ³öÓɺËСÌå×é³ÉµÄÄîÖé×´½á¹¹£¬¿ÉÒÔ¿´µ½ÓÉÒ»Ìõϸ˿Á¬½Ó×ŵÄÒ»Á¬´®Ö±¾¶Îª10nmµÄÇò×´Ìå¡£ ]s Euh~F  
ºËСÌåÊÇÓÉH2A¡¢H2B¡¢H3¡¢H4¸÷Á½¸ö·Ö×ÓÉú³ÉµÄ°Ë¾ÛÌåºÍÓÉ´óÔ¼200bpDNA×é³ÉµÄ¡£°Ë¾ÛÌåÔÚÖм䣬DNA·Ö×ÓÅÌÈÆÔÚÍ⣬¶øH1ÔòÔÚºËСÌåµÄÍâÃ档ÿ¸öºËСÌåÖ»ÓÐÒ»¸öH1¡£ 8(`e\)%l0  
ÔÚºËСÌåÖÐDNAÅÌÈÆ×éµ°°×°Ë¾ÛÌåºËÐÄ£¬´Ó¶øʹ·Ö×ÓÊÕËõ³É1/7£¬200bpDNAµÄ³¤¶ÈԼΪ68nm£¬È´±»Ñ¹ËõÔÚ10nmµÄºËСÌåÖС£µ«ÊÇ£¬ÈËÖÐÆÚȾɫÌåÖк¬3.3¡Á109¼î»ù¶Ô£¬ÆäÀíÂÛ³¤¶ÈÓ¦ÊÇ180cm£¬Õâô³¤µÄDNA±»°üº¬ÔÚ46¸ö51¦Ìm³¤µÄÔ²ÖùÌ壨ȾɫÌ壩ÖУ¬ÆäѹËõ±ÈԼΪ104¡£ h GA2.{  
Xc[ym  
2£®È¾É«ÌåÖеĺËËá×é³É !,ODczWvh  
¢Å²»Öظ´ÐòÁÐ ÔÚµ¥±¶Ìå»ùÒò×éÀÕâЩÐòÁÐÒ»°ãÖ»ÓÐÒ»¸ö»ò¼¸¸ö¿½±´£¬ËüÕ¼DNA×ÜÁ¿µÄ40%£­80%¡£²»Öظ´ÐòÁг¤Ô¼750£­2000dp£¬Ï൱ÓÚÒ»¸ö½á¹¹»ùÒòµÄ³¤¶È¡£µ¥¿½±´»ùÒòͨ¹ý»ùÒòÀ©ÔöÈԿɺϳɴóÁ¿µÄµ°°×ÖÊ£¬ÈçÒ»¸ö²ÏË¿Ðĵ°°×»ùÒò¿É×÷Ϊģ°åºÏ³É104¸öË¿Ðĵ°°×mRNA£¬Ã¿¸ömRNA¿É´æ»î4d£¬¹²ºÏ³É105¸öË¿Ðĵ°°×£¬ÕâÑù£¬ÔÚ¼¸ÌìÖ®ÄÚ£¬Ò»¸öµ¥¿½±´Ë¿Ðĵ°°×»ùÒò¾Í¿ÉÒԺϳÉ109¸öË¿Ðĵ°°×·Ö×Ó ¡£ "]jN'N(.  
#_^ p~:  
¢ÆÖжÈÖظ´ÐòÁÐ ÕâÀàÖظ´ÐòÁеÄÖظ´´ÎÊýÔÚ10£­104Ö®¼ä£¬Õ¼×ÜDNAµÄ10%£­40%¡£¸÷ÖÖrRNA¡¢tRNA ¼°×éµ°°×»ùÒòµÈ¶¼ÊôÕâÒ»Àà¡£ 2|7:`e~h  
·ÇÖÞצó¸µÄ18S¡¢5.8S¼°28SrRNA»ùÒòÊÇÁ¬ÔÚÒ»ÆðµÄ£¬Öмä¸ô×Ų»×ªÂ¼µÄ¼ä¸ôÇø£¬ÕâЩµ¥Î»ÔÚDNAÁ´ÉÏ´®ÁªÖظ´Ô¼5000´Î¡£ÔÚÂÑϸ°ûÐγɹý³ÌÖÐÕâЩ»ùÒò¿É½øÐм¸Ç§´Î²»Í¬±ÈÀýµÄ¸´ÖÆ£¬²úÉú2¡Á106¸ö¿½±´£¬Ê¹rDNAÕ¼ÂÑϸ°ûDNAµÄ75%£¬´Ó¶øʹ¸Ãϸ°ûÄÜ»ýÀÛ1012¸öºËÌÇÌå¡£ 25Ee+&&%  
d"5_x]Z;  
¢Ç¸ß¶ÈÖظ´ÐòÁСª¡ªÎÀÐÇDNA ÕâÀàDNAÖ»ÔÚÕæºËÉúÎïÖз¢ÏÖ£¬Õ¼»ùÒò×éµÄ10%¡ª60%£¬ÓÉ6¡ª100¸ö¼î»ù×é³É£¬ÔÚDNAÁ´ÉÏ´®ÁªÖظ´¼¸°ÙÍò´Î¡£ÓÉÓÚ¼î»ùµÄ×é³É²»Í¬£¬ÔÚCsClÃܶÈÌݶÈÀëÐÄÖÐÒ×ÓëÆäËûDNA·Ö¿ª£¬Ðγɺ¬Á¿½Ï´óµÄÖ÷·å¼°¸ß¶ÈÖظ´ÐòÁÐС·å£¬ºóÕßÓÖ³ÆÎÀÐÇÇø´ø£¨·å£©¡£ dWzf C@]  
¸ßµÈÕæºËÉúÎïDNAÎÞÂ۴ӽṹ»¹Êǹ¦ÄÜ¿´¶¼¼«Îª¸´ÔÓ£¬ÒÔСÊóΪÀý£º v RtERFL  
1.СÊó×ÜDNAµÄ10£¥ÊÇСÓÚ10bpµÄ¸ß¶ÈÖظ´ÐòÁУ¬Öظ´ÊýÊ®Íòµ½ÉÏ°ÙÍò´Î/genome¡£ -W6@[5c  
2.×ÜDNAµÄ20£¥ÊÇÖظ´Êýǧ´Î¡¢³¤Ô¼Êý°ÙbpµÄÖеÈÖظ´ÐòÁС£ uPl7u 1c  
3.×ÜDNAµÄ70£¥ÊDz»Öظ´»òµÍÖظ´ÐòÁÐ,¾ø´ó²¿·Ö¹¦ÄÜ»ùÒò¶¼Î»ÓÚÕâÀàÐòÁÐÖС£ 1D[V{) #  
Centromere£ºÊÇϸ°ûÓÐË¿·ÖÁÑÆÚ¼ä·Ä´¸Ìåµ°°×ÖÊÓëȾɫÌåµÄ½áºÏλµã£¨attachment point£©£¬ÕâÖÖ½áºÏ¶ÔÓÚȾɫÌå¶ÔÔÚ×Óϸ°ûÖеÄÓÐÐòºÍƽ¾ù·ÖÅäÖÁ¹ØÖØÒª¡£ÔÚ½ÍĸÖУ¬centromereµÄ¹¦Äܵ¥Î»³¤Ô¼130 bp£¬¸»º¬AT ¼î»ù¶Ô¡£ÔڸߵÈÕæºËϸ°ûÖУ¬centromere¶¼ÊÇÓɳ¤Ô¼5£­10 bp¡¢·½ÏòÏàͬµÄ¸ß¶ÈÖظ´ÐòÁÐËù×é³É¡£ I]n X6=j5  
Telomeres are sequences at the ends of eukaryotic Chromosomes that help stabilize them¡£ ½ÍĸTelomeresÒ»°ãÒÔ100 bp×óÓÒ²»¾«È·Öظ´ÐòÁÐËù×é³É¡£ t >quY$}4  
5¡¯(TxGy)n 2Bi]t%<{  
3¡¯(AxCy)n Q}Ah{H0C  
ÆäÖÐX¡¢YÒ»°ãΪ1£­4£¬µ¥Ï¸°ûÕæºËÉúÎïÖÐn³£Îª20£­100£¬¸ßµÈÕæºËÉúÎïÖÐ>1500¡£ {8mJ<b>VA  
ȾɫÌåÄ©¶ËµÄÏßÐÔÖظ´ÐòÁв»Äܱ»DNA polymarase Ëù׼ȷ¸´ÖÆ£¬ËüÃÇÒ»°ãÔÚDNA¸´ÖÆÍê³ÉÒÔºóÓÉtelomaraseºÏ³Éºó¼Óµ½È¾É«ÌåÄ©¶Ë¡£ `yq) y>_  
Alu£¨³¤Ô¼300bp£©ÊÇÈËÀà¸ß¶ÈÖظ´ÐòÁÐ,ÒòΪ¸ÃÐòÁÐÖдøÓÐAluIµÄʶ±ðÐòÁжøµÃÃû¡£ÊýÊ®Íò¸öAluÖظ´ÐòÁÐÉ¢²¼ÓÚÕû¸öÈËÀà»ùÒò×éÖУ¬´ïµ½×ÜÐòÁеÄ1£­3£¥¡£AluÓëÆäËü¸ß¶ÈÖظ´ÐòÁй²Õ¼ÈËÀàDNAµÄ10£¥ÒÔÉÏ¡£ K"[jrvZ=  
'`k  
3£®È¾É«ÌåÖеĵ°°×ÖÊ ?#c "wA&  
ȾɫÌåÉϵĵ°°×ÖÊ°üÀ¨×éµ°°×ºÍ·Ç×éµ°°×¡£×éµ°°×ÊÇȾɫÌåµÄ½á¹¹µ°°×£¬ËüÓëDNA×é³ÉºËСÌ塣ͨ³£¿ÉÒÔÓÃ2mol/L NaCl»ò0.25mol/LµÄHCl/H2SO4´¦Àíʹ×éµ°°×ÓëDNA·Ö¿ª¡£×éµ°°×·ÖΪH1¡¢H2A¡¢H2B¡¢H3¼°H4¡£ÕâЩ×éµ°°×¶¼º¬ÓдóÁ¿µÄÀµ°±ËáºÍ¾«°±ËᣬÆäÖÐH3¡¢H4¸»º¬¾«°±ËᣬH1¸»º¬Àµ°±Ë᣻H2A¡¢H2B½éÓÚÁ½ÕßÖ®¼ä¡£ hgYFR6VH  
¢Å×éµ°°×µÄÒ»°ãÌØÐÔ BO}IN#  
½ø»¯Éϵļ«¶Ë±£ÊØÐÔ¡£Å£¡¢Öí¡¢´óÊóµÄH4°±»ùËáÐòÁÐÍêÈ«Ïàͬ¡£Å£µÄH4ÐòÁÐÓëÍ㶹ÐòÁÐÏà±ÈÖ»ÓÐÁ½¸ö°±»ùËáµÄ²îÒ죨Í㶹H4ÖеÄÒìÁÁ°±»ùËá60¡úçÓ°±Ëá60£¬¾«°±Ëá¡úÀµ°±Ëᣩ¡£H3µÄ±£ÊØÐÔÒ²ºÜ´ó£¬ÀðÓãÓëСţÐØÏÙµÄH3Ö»²îÒ»¸ö°±»ùËᣬСţÐØÏÙÓëÍ㶹H3Ö»²î4¸ö°±»ùËá¡£ 5M>p%/  
ÎÞ×éÖ¯ÌØÒìÐÔ¡£µ½Ä¿Ç°ÎªÖ¹£¬½ö·¢ÏÖÄñÀà¡¢ÓãÀ༰Á½ÆÜÀàºìϸ°ûȾɫÌå²»º¬H1¶ø´øÓÐH5£¬¾«Ï¸°ûȾɫÌåµÄ×éµ°°×ÊÇÓ㾫µ°°×¡£ rhzI*nwOT  
ëÄÁ´ÉÏ°±»ùËá·Ö²¼µÄ²»¶Ô³ÆÐÔ¡£¼îÐÔ°±»ùËἯÖзֲ¼ÔÚN¶ËµÄ°ëÌõÁ´ÉÏ¡£ÀýÈ磬N¶ËµÄ°ëÌõÁ´ÉϾ»µçºÉΪ+16£¬C¶ËÖ»ÓÐ+3£¬´ó²¿·ÖÊèË®»ùÍŶ¼·Ö²¼ÔÚC¶Ë¡£ O<wH+k[  
×éµ°°×µÄÐÞÊÎ×÷ÓᣰüÀ¨¼×»ù»¯¡¢ÒÒ»ù»¯¡¢Á×Ëữ¼°ADPºËÌÇ»ù»¯µÈ¡£ t{UWb~"  
)/f#~$ws  
¢Æ·Ç×éµ°°×µÄÒ»°ãÌØÐÔ O:+y/c  
ȾɫÌåÉϳýÁË´æÔÚ´óÔ¼ÓëDNAµÈÁ¿µÄ×éµ°°×ÒÔÍ⣬»¹´æÔÚ´óÁ¿µÄ·Ç×éµ°°×¡£·Ç×éµ°°×µÄ¶àÑùÐÔ¡£·Ç×éµ°°×µÄÁ¿´óÔ¼ÊÇ×éµ°°×µÄ60%¡«70%£¬µ«ËüµÄÖÖÀàÈ´ºÜ¶à£¬Ô¼ÔÚ20-100ÖÖÖ®¼ä£¬ÆäÖг£¼ûµÄÓÐ15-20ÖÖ¡£ ·Ç×éµ°°×µÄ×é֯רһÐÔºÍÖÖÊôרһÐÔ¡£ >r)UDa+  
(3)¼¸Àà³£¼ûµÄ·Ç×éµ°°× j/O9LygB  
a.HMGµ°°×£¨high mobility group protein£©¡£ÕâÊÇÒ»ÀàÄÜÓõÍÑΣ¨0.35mol/L NaCl£©ÈÜÒº³éÌá¡¢ÄÜÈÜÓÚ2%µÄÈýÂÈÒÒËá¡¢Ïà¶Ô·Ö×ÓÖÊÁ¿½ÏµÍµÄ·Ç×éµ°°×£¬Ïà¶Ô·Ö×ÓÖÊÁ¿¶¼ÔÚ3.0¡Á104ÒÔÏ¡£ nzxHd7NIZ  
b. DNA½áºÏµ°°×¡£ÓÃ2mol/L NaCl³ýȥȫ²¿×éµ°°×ºÍ70%·Ç×éµ°°×ºó£¬»¹ÓÐÒ»²¿·Öµ°°×±ØÐëÓÃ2mol/L NaClºÍ5mol/LÄòËزÅÄÜÓëDNA½âÀë¡£ÕâЩµ°°×·Ö×ÓÁ¿½ÏµÍ£¬Ô¼Õ¼·Ç×éµ°°×µÄ20%£¬È¾É«ÖʵÄ8%¡£ us5Zi#}  
*fd:(dN|  
Æß. Ô­ºËÓëÕæºËȾɫÌåDNA±È½Ï )w}'kih  
Ô­ºËÉúÎïÖÐÒ»°ãÖ»ÓÐÒ»ÌõȾɫÌåÇҴ󶼴øÓе¥¿½±´»ùÒò£¬Ö»ÓкÜÉÙÊý»ùÒò¡²ÈçrRNA»ùÒò¡³ÊÇÒԶ࿽±´ÐÎʽ´æÔÚ£» wmK;0 )|H  
Õû¸öȾɫÌåDNA¼¸ºõÈ«²¿Óɹ¦ÄÜ»ùÒòÓëµ÷¿ØÐòÁÐËù×é³É£» O>f*D+A-  
¼¸ºõÿ¸ö»ùÒòÐòÁж¼ÓëËüËù±àÂëµÄµ°°×ÖÊÐòÁгÊÏßÐÔ¶ÔӦ״̬¡£ 902A,*qq  
Viral DNA molecules are relatively small q~18JB4WPJ  
HIV = 9000 nt RNA s(5(zcBK  
Q¦Â = 4200 nt X,M!Tp  
Bactaria DNA is 100 times > than viral }j6|+  
E. coli 4639221 bp double-stranded {>64-bU  
Contour length = 1.7mm, 850±¶Ï¸¾ú±¾Éí³¤¶È¡£Ï¸¾úÖг£³£´øÓÐÖÊÁ£DNA¡£ i+Ne.h  
Eucaryotic cells <b4} B   
¹ûÓ¬´øÓÐ25±¶ÓÚE. Coli µÄDNA,ÈËÀà´øÓÐ600±¶ÓÚE. Coli µÄDNA. Eucaryotic DNA ÖлùÒòÃܶÈÃ÷ÏÔµÍÓÚÔ­ºËºÍ²¡¶¾¡£ÈçÈËDNAÖÐƽ¾ùÿºÁÃ×Ö»´øÓÐ50¸ö»ùÒò,¶øE. ColiÖлùÒòÃܶÈÿºÁÃ×DNA´øÓÐ2400¸ö»ùÒò£¡Ò»¸öÈËϸ°ûÖÐËù´øÓеÄDNAÔ¼ÓÐ2m/1.7mmϸ¾ú¡£³ÉÈË´øÓÐ1X10^14¸öϸ°û£¬³ÉÈËÌåÄÚÈ«²¿DNAµÄ×ܳ¤¶È£¨Contour Length£©£½ 2X10^11Km V/\`:  
}>f%8O}  
we}5'bS>  
Ss{5'SF)$c  
------------------------------------------------------ !#5y%Bf  
j$u  
µÚÈý½² µ°°×ÖÊºÏ³É \(?d2$0m  
Ò».»ùÒòÓë»ùÒò±í´ïµÄÒ»°ã¸ÅÄî f/kYm\Zc  
»ùÒò×÷ΪΨһÄܹ»×ÔÖ÷¸´ÖÆ¡¢ÓÀ¾Ã´æÔڵĵ¥Î»£¬ÆäÉúÀíѧ¹¦ÄÜÒÔµ°°×ÖÊÐÎʽµÃµ½±í´ï¡£DNAÐòÁÐÊÇÒÅ´«ÐÅÏ¢µÄÖü´æÕߣ¬Ëüͨ¹ý×ÔÖ÷¸´ÖƵõ½ÓÀ´æ£¬²¢Í¨¹ýת¼Éú³ÉmRNA£¬·­ÒëÉú³Éµ°°×ÖʵĹý³Ì¿ØÖÆËùÓÐÉúÃüÏÖÏó¡£ /ml+b8@  
±àÂëÁ´£¨coding strand£©ÓÖ³Æsense strand£¬ÊÇÖ¸ÓëmRNAÐòÁÐÏàͬµÄÄÇÌõÁ´¡£·Ç±àÂëÁ´£¨anticoding strand£©£¬ÓÖ³Æantisense strand£¬ÊÇÖ¸ÄÇÌõ¸ù¾Ý¼î»ù»¥²¹Ô­ÔòÖ¸µ¼mRNAÉúÎïºÏ³ÉµÄDNAÁ´¡£ K^/.v<w  
Genetic information is perpetuated by replication£¨¸´ÖÆ£©in which a double- stranded nucleic acid is duplicated to give identical copies. ykx13|iR  
»ùÒò±í´ï°üÀ¨×ªÂ¼£¨transcription£©ºÍ·­Ò루translation£©Á½¸ö½×¶Î¡£×ªÂ¼ÊÇÖ¸¿½±´³öÒ»ÌõÓëDNAÁ´ÐòÁÐÍêÈ«Ïàͬ£¨³ýÁËT¡úUÖ®Í⣩µÄRNAµ¥Á´µÄ¹ý³Ì£¬ÊÇ»ùÒò±í´ïµÄºËÐIJ½Öè¡£·­ÒëÊÇÖ¸ÒÔÐÂÉúµÄmRNAΪģ°å£¬°ÑºËÜÕËáÈýÁª×ÓÒÅ´«ÃÜÂë·­Òë³É°±»ùËáÐòÁС¢ºÏ³Éµ°°×ÖʶàëÄÁ´µÄ¹ý³Ì£¬ÊÇ»ùÒò±í´ïµÄ×îÖÕÄ¿µÄ¡£ %0u5d$bq  
Ö»ÓÐmRNAËùЯ´øµÄÒÅ´«ÐÅÏ¢²Å±»ÓÃÀ´Ö¸µ¼µ°°×ÖÊÉúÎïºÏ³É£¬ËùÒÔÈËÃÇÒ»°ãÓÃU¡¢C¡¢A¡¢GÕâ4ÖÖºËÜÕËá¶ø²»ÊÇT¡¢C¡¢A¡¢GµÄ×éºÏÀ´±íʾÒÅ´«ÐÔ×´¡£Ëùν·­ÒëÊÇÖ¸½«mRNAÁ´ÉϵĺËÜÕËá´ÓÒ»¸öÌض¨µÄÆðʼλµã¿ªÊ¼£¬°´Ã¿3¸öºËÜÕËá´ú±íÒ»¸ö°±»ùËáµÄÔ­Ôò£¬ÒÀ´ÎºÏ³ÉÒ»Ìõ¶àëÄÁ´µÄ¹ý³Ì¡£ C{-Dv-<A>  
fA V.Mj-  
¶þ. ÒÅ´«ÃÜÂ롪¡ªÈýÁª×Ó 't \sXN+1  
mRNAÉÏÿ3¸öºËÜÕËá·­Òë³Éµ°°×ÖʶàëÄÁ´ÉϵÄÒ»¸ö°±»ùËᣬÕâ3¸öºËÜÕËá¾Í³ÆΪһ¸öÃÜÂ룬Ҳ½ÐÈýÁª×ÓÃÜÂë¡£·­Òëʱ´ÓÆðʼÃÜÂë×ÓAUG¿ªÊ¼£¬ÑØmRNA5¡¯¡ú3¡¯µÄ·½ÏòÁ¬ÐøÔĶÁÖ±µ½ÖÕÖ¹ÃÜÂë×Ó£¬Éú³ÉÒ»Ìõ¾ßÓÐÌض¨ÐòÁеĶàëÄÁ´¡£ ! }eq~3  
mRNAÖÐÖ»ÓÐ4ÖÖºËÜÕËᣬ¶øµ°°×ÖÊÖÐÓÐ20ÖÖ°±»ùËᣬÈôÒÔÒ»ÖÖºËÜÕËá´ú±íÒ»ÖÖ°±»ùËᣬֻÄÜ´ú±í4ÖÖ(41=4)¡£ÈôÒÔÁ½ÖÖºËÜÕËá×÷Ϊһ¸öÃÜÂ루¶þÁª×Ó£©£¬ÄÜ´ú±í42=16ÖÖ°±»ùËá¡£¶ø¼Ù¶¨ÒÔ3¸öºËÜÕËá´ú±íÒ»¸ö°±»ùËᣬÔò¿ÉÒÔÓÐ43=64ÖÖÃÜÂ룬Âú×ãÁ˱àÂë20ÖÖ°±»ùËáµÄÐèÒª¡£ Vn^8nS  
50-60Äê´úÆÆÒëÒÅ´«ÃÜÂë·½ÃæµÄÈýÏîÖØÒª³É¹û£º /byF:iYI  
£¨1£©Paul ZamecnikµÈÈË֤ʵϸ°ûÖе°°×Öʺϳɵij¡Ëù¡£ËûÃÇ°Ñ·ÅÉäÐÔ±ê¼ÇµÄ°±»ùËá×¢Éäµ½´óÊóÌåÄÚ£¬¾­¹ýÒ»¶Îʱ¼äºóÊÕ»ñÆä¸ÎÔ࣬½øÐÐÕáÌÇÌݶȳÁµí²¢·ÖÎö¸÷ÖÖϸ°û³É·ÝÖеķÅÉäÐÔµ°°×ÖÊ¡£ K(NP%:  
Èç¹û×¢Éäºó¾­ÊýСʱ£¨»òÊýÌ죩ÊÕ»ñ¸ÎÔ࣬ËùÓÐϸ°û³É·ÝÖж¼´øÓзÅÉäÐÔ±ê¼ÇµÄµ°°×ÖÊ;  pXNH  
Èç¹û×¢Éäºó¼¸·ÖÖÓÄÚ¼´ÊÕ»ñ¸ÎÔ࣬ÄÇô£¬·ÅÉäÐÔ±ê¼ÇÖ»´æÔÚÓÚº¬ÓкËÌÇÌå¿ÅÁ£µÄϸ°ûÖʳɷÝÖС£ :h0!gi qoQ  
£¨2£©Francis CrickµÈÈ˵ÚÒ»´Î֤ʵֻÓÐÓÃÈýÁª×ÓÃÜÂëµÄÐÎʽ²ÅÄÜ°Ñ°üº¬ÔÚÓÉAUGCËĸö×Öĸ×é³ÉÒÅ´«ÐÅÏ¢£¨ºËËᣩ׼ȷÎÞÎóµØ·­Òë³ÉÓÉ20ÖÖ²»Í¬°±»ùËá×é³ÉµÄµ°°×ÖÊÐòÁУ¬ÊµÏÖÒÅ´«ÐÅÏ¢µÄ±í´ï¡£ dDYor-g>  
ʵÑé1: d)%l-jj9,  
ÓÃß¹à¤ÀàÊÔ¼Á£¨ÓÕµ¼ºËÜÕËá²åÈë»ò¶ªÊ§£©´¦ÀíT4ÊɾúÌårIIλµãÉϵÄÁ½¸ö»ùÒò£¬Ê¹Ö®·¢ÉúÒÆÂëÍ»±ä£¨frame-shift£©£¬¾ÍÉú³ÉÍêÈ«²»Í¬µÄ¡¢Ã»Óй¦Äܵĵ°°×ÖÊ¡£ wC<FF2T  
ʵÑé2: Pl|*+g  
Ñо¿Ñ̲ݻµËÀÎÀÐDz¡¶¾·¢ÏÖ£¬ÆäÍâ¿Çµ°°×ÑÇ»ùÓÉ400¸ö°±»ùËá×é³É£¬ÏàÓ¦µÄRNAƬ¶Î³¤1200¸öºËÜÕËᣬÓëÃÜÂëÈýÁª×ÓÌåϵÕýºÃÏàÎǺϡ£ .?F`H[^)^u  
ʵÑé3: -zH-9N*c  
ÒÔ¾ù¾ÛÎïΪģ°åÖ¸µ¼¶àëĵĺϳɡ£ ÔÚº¬ÓÐtRNA¡¢ºËÌÇÌå¡¢AA-tRNAºÏ³Éø¼°ÆäËüµ°°×ÖÊÒò×ÓµÄϸ°û³éÌáÎïÖмÓÈëmRNA»òÈ˹¤ºÏ³ÉµÄ¾ù¾ÛÎï×÷Ϊģ°åÒÔ¼°ATP¡¢GTP¡¢°±»ùËáµÈ³É·ÖʱÓÖÄܺϳÉеÄëÄÁ´£¬ÐÂÉúëÄÁ´µÄ°±»ùËá˳ÐòÓÉÍâ¼ÓµÄÄ£°åÀ´¾ö¶¨¡£ qm=9!jqC;  
1961Ä꣬NirenbergµÈÒÔpoly£¨U£©×÷Ä£°åʱ·¢ÏֺϳÉÁ˶à¾Û±½±û°±Ëᣬ´Ó¶øÍƳöUUU´ú±í±½±û°±ËᣨPhe£©¡£ÒÔpoly£¨C£©¼°poly£¨A£©×öÄ£°å·Ö±ðµÃµ½¶à¾Û¸¬°±ËáºÍ¶à¾ÛÀµ°±Ëá¡£ \3t)7.:4  
ʵÑé4: b Sg]FBaW  
ÒÔÌض¨ÐòÁеĹ²¾ÛÎïΪģ°åÖ¸µ¼¶àëĵĺϳɡ£ÒÔ¶à¾Û¶þºËÜÕËá×÷Ä£°å¿ÉºÏ³ÉÓÉ2¸ö°±»ùËá×é³ÉµÄ¶àëÄ£¬ ' b,zE[Q  
5¡¯¡­UGU GUG UGU GUG UGU GUG¡­3¡¯,²»¹Ü¶ÁÂë´ÓU¿ªÊ¼»¹ÊÇ´ÓG¿ªÊ¼£¬¶¼Ö»ÄÜÓÐUGU£¨Cys£©¼°GUG£¨Val£©Á½ÖÖÃÜÂë×Ó¡£ h5; +5B}D  
ʵÑé5: y0t-e   
ÒÔ¹²¾ÛÈýºËÜÕËá×÷Ϊģ°å¿ÉµÃµ½ÓÐ3ÖÖ°±»ùËá×é³ÉµÄ¶àëÄ¡£ÈçÒÔ¶à¾Û£¨UUC£©ÎªÄ£°å£¬¿ÉÄÜÓÐ3ÖÖÆð¶Á·½Ê½£º lb)i0`AN+  
5¡¯¡­UUC UUC UUC UUC UUC¡­3¡¯»ò 5¡¯¡­UCU UCU UCU UCU UCU¡­3¡¯»ò 5¡¯¡­CUU CUU CUU CUU CUU¡­3¡¯·Ö±ð²úÉúUUC£¨Phe£©¡¢UCU£¨Ser£©»òCUU£¨Leu£©. $yZP"AsAR  
¶à¾ÛÈýºËÜÕËáΪģ°åʱҲ¿ÉÄÜÖ»ºÏ³É2ÖÖ¶àëÄ£º5¡¯¡­GUA GUA GUA GUA GUA¡­3¡¯»ò5¡¯¡­UAG UAG UAG UAG UAG¡­3¡¯ @j r$4pM?  
»ò5¡¯¡­AGU AGU AGU AGU AGU¡­3¡¯ÓɵڶþÖÖ¶ÁÂ뷽ʽ²úÉúµÄÃÜÂë×ÓUAGÊÇÖÕÖ¹ÃÜÂ룬²»±àÂëÈκΰ±»ùËᣬÒò´Ë£¬Ö»²úÉúGUA£¨Val£©»òAGU£¨Ser£©¡£ (>om.FM  
ʵÑé6: Z3 na.>Z  
ÒÔËæ»ú¶à¾ÛÎïÖ¸µ¼¶àëĺϳɡ£NirenbergµÈ¼°OchoaµÈÓÖÓø÷ÖÖËæ»úµÄ¶à¾ÛÎï×÷Ä£°åºÏ³É¶àëÄ¡£ÀýÈ磬ÒÔÖ»º¬A¡¢CµÄ¶à¾ÛºËÜÕËá×÷Ä£°å£¬ÈÎÒâÅÅÁÐʱ¿É³öÏÖ8ÖÖÈýÁª×Ó£¬¼´CCC¡¢CCA¡¢CAC¡¢ACC¡¢CAA¡¢ACA¡¢AAC¡¢AAA£¬»ñµÃÓÉAsn¡¢His¡¢Pro¡¢Gln¡¢Thr¡¢LysµÈ6ÖÖ°±»ùËá×é³ÉµÄ¶àëÄ¡£ _lOyT$DN  
`]2y=f<{X  
£¨3£©°±»ùËáµÄ¡°»î»¯¡±ÓëºËÌÇÌå½áºÏ¼¼Êõ¡£ j+3=&PkA.]  
Èç¹û°Ñ°±»ùËáÓëATPºÍ¸ÎÔàϸ°ûÖʹ²ÅàÑø£¬°±»ùËá¾Í»á±»¹Ì¶¨ÔÚijЩÈÈÎȶ¨ÇÒ¿ÉÈÜÐÔRNA·Ö×Ó£¨transfer RNA£¬tRNA£©ÉÏ¡£ÏÖ½«°±»ùËá»î»¯ºóµÄ²úÎï³ÆΪ°±»ùõ£-tRNA£¨aminoacyl-tRNA£©£¬²¢°Ñ´ß»¯¸Ã¹ý³ÌµÄø³ÆΪ°±»ùõ£ºÏ³Éø£¨aminoacyl-tRNA Synthetase£©¡£ )]JQlm:H  
ÒÔÈ˹¤ºÏ³ÉµÄÈýºËÜÕËáÈçUUU¡¢UCU¡¢UGUµÈΪģ°å£¬ÔÚº¬ºËÌÇÌå¡¢AA-tRNAµÄ·´Ó¦ÒºÖб£Îºóͨ¹ýÏõËáÏËάËØÂËĤ£¬Ö»ÓÐÓÎÀëµÄAA-tRNAÒòÏà¶Ô·Ö×ÓÖÊÁ¿Ð¡¶øͨ¹ýÂËĤ£¬¶øºËÌÇÌå»òÓëºËÌÇÌå½áºÏµÄAA-tRNAÔòÁôÔÚÂËĤÉÏ£¬ÕâÑù¿É°ÑÒѽáºÏÓëδ½áºÏµÄAA-tRNA·Ö¿ª¡£ $I3}% '`+  
µ±ÌåϵÖдøÓжà¾ÛºËÜÕËáÄ£°åʱ£¬´Ó´ó³¦¸Ë¾úÖÐÌáÈ¡µÄºËÌÇÌå¾­³£ÓëÌØÒìÐÔ°±»ùõ£-tRNAÏà½áºÏ¡£Èç¹û°ÑºËÌÇÌåÓëpoly£¨U£©ºÍPhe-tRNAPhe¹²ÎÂÓý£¬ºËÌÇÌå¾ÍÄÜͬʱÓëpoly£¨U£©ºÍPhe-tRNAPheÏà½áºÏ¡£ VC NQ}h[D  
4ÖÖºËÜÕËá×é³É61¸ö±àÂë°±»ùËáµÄÃÜÂë×ÓºÍ3¸öÖÕÖ¹ÃÜÂë×Ó£¬ËüÃDz»ÄÜÓëtRNAµÄ·´ÃÜÂë×ÓÅä¶Ô£¬µ«Äܱ»ÖÕÖ¹Òò×Ó»òÊÍ·ÅÒò×Óʶ±ð£¬ÖÕÖ¹ëÄÁ´µÄºÏ³É¡£ÓÉÒ»ÖÖÒÔÉÏÃÜÂë×Ó±àÂëͬһ¸ö°±»ùËáµÄÏÖÏó³ÆΪ¼ò²¢£¨degeneracy£©£¬¶ÔÓ¦ÓÚͬһ°±»ùËáµÄÃÜÂë×Ó³ÆΪͬÒåÃÜÂë×Ó£¨synonymous codon£©¡£ ,xC@@>f  
k'd=|U;(FV  
Èý£®ÃÜÂë×Ӻͷ´ÃÜÂë×ÓµÄÏ໥×÷Óà W% }zwQ  
µ°°×ÖÊÉúÎïºÏ³É¹ý³ÌÖУ¬tRNAµÄ·´ÃÜÂë×Óͨ¹ý¼î»ùµÄ·´ÏòÅä¶ÔÓëmRNAµÄÃÜÂë×ÓÏ໥×÷Óá£1966Ä꣬Crick¸ù¾ÝÁ¢Ì廯ѧԭÀíÌá³ö°Ú¶¯¼Ù˵£¨wobble hypothesis£©£¬½âÊÍÁË·´ÃÜÂë×ÓÖÐijЩϡÓгɷÖÈçIÒÔ¼°Ðí¶àÓÐ2¸öÒÔÉÏͬԴÃÜÂë×ÓµÄÅä¶ÔÎÊÌâ¡£ k?Iq 6  
Wobble hypothesis >uz3 O?z P  
¢Ù ÈÎÒâÒ»¸öÃÜÂë×ÓµÄÇ°Á½Î»¼î»ù¶¼ÓëtRNA anticodonÖеÄÏàÓ¦¼î»ùÐγÉWatson-Crick¼î»ùÅä¶Ô¡£ &m@DK>  
¢Ú ·´ÃÜÂë×ÓµÚһλÊÇA»òCʱ£¬Ö»ÄÜʶ±ðÒ»¸öÃÜÂë×Ó¡£µ±·´ÃÜÂë×ÓµÚһλÊÇU»òGʱ£¬ÄÜʶ±ðÁ½¸öÃÜÂë×Ó¡£µ±Inosine£¨I£©×÷Ϊ·´ÃÜÂë×ÓµÚһλʱ£¬ÄÜʶ±ðÈý¸öÃÜÂë×Ó¡£ kAk+ Sq^n  
¢Û Èç¹ûÊý¸öÃÜÂë×Óͬʱ±àÂëÒ»¸ö°±»ùËᣬ·²ÊǵÚÒ»¡¢¶þλ¼î»ù²»ÏàͬµÄÃÜÂë×Ó¶¼¶ÔÓ¦ÓÚ¸÷×ÔµÄtRNA¡£ yKOC1( ~  
¢Ü ¸ù¾ÝÉÏÊö¹æÔò£¬ÖÁÉÙÐèÒª32ÖÖ²»Í¬µÄtRNA²ÅÄÜ·­Òë61¸öÃÜÂë×Ó¡£ b U>.Bp]  
Dn.%+im-u  
ËÄ£®tRNA Ivc/g,  
tRNAÔÚµ°°×ÖʺϳÉÖд¦ÓڹؼüµØ룬±»³ÆΪµÚ¶þÒÅ´«ÃÜÂë¡£Ëü²»µ«Îª½«Ã¿¸öÈýÁª×ÓÃÜÂë·­Òë³É°±»ùËáÌṩÁ˽ӺÏÌ壬»¹Îª×¼È·ÎÞÎóµØ½«ËùÐè°±»ùËáÔËË͵½ºËÌÇÌåÉÏÌṩÁËÔØÌå¡£ËùÓеÄtRNA¶¼Äܹ»ÓëºËÌÇÌåµÄPλµãºÍAλµã½áºÏ£¬´Ëʱ£¬tRNA·Ö×ÓÈýÒ¶²ÝÐͶ¥¶ËÍ»Æð²¿Î»Í¨¹ýÃÜÂë×Ó£º·´ÃÜÂë×ÓµÄÅä¶ÔÓëmRNAÏà½áºÏ£¬¶øÆä3¡¯Ä©¶ËÇ¡ºÃ½«ËùתÔ˵ݱ»ùËáË͵½ÕýÔÚÑÓÉìµÄ¶àëÄÉÏ¡£´ú±íÏàͬ°±»ùËáµÄtRNA³ÆΪͬ¹¤tRNA¡£ÔÚÒ»¸öͬ¹¤tRNA×éÄÚ£¬ËùÓÐtRNA¾ùרһÓÚÏàͬµÄ°±»ùõ£- tRNAºÏ³Éø¡£ ?xCWg.#l4V  
1¡¢tRNAµÄÈýÒ¶²ÝÐͶþ¼¶½á¹¹ glRHn? p  
ÊÜÌå±Û£¨acceptor arm£©Ö÷ÒªÓÉÁ´Á½¶ËÐòÁмî»ùÅä¶ÔÐγɵĸË×´½á¹¹ºÍ3¡¯¶ËÄ©Åä¶ÔµÄ3-4¸ö¼î»ùËù×é³É£¬Æä3¡¯¶ËµÄ×îºó3¸ö¼î»ùÐòÁÐÓÀÔ¶ÊÇCCA£¬×îºóÒ»¸ö¼î»ùµÄ3¡¯»ò2¡¯×ÔÓÉôÇ»ù£¨¡ªOH£©¿ÉÒÔ±»°±õ£»¯¡£T¦ÕC±ÛÊǸù¾Ý3¸öºËÜÕËáÃüÃûµÄ£¬ÆäÖЦձíʾÄâÄòà×ण¬ÊÇtRNA·Ö×ÓËùÓµÓеIJ»³£¼ûºËÜÕËá¡£·´ÃÜÂë×Ó±ÛÊǸù¾ÝλÓÚÌ×Ë÷ÖÐÑëµÄÈýÁª·´ÃÜÂë×ÓÃüÃûµÄ¡£D±ÛÊǸù¾ÝËüº¬ÓжþÇâÄòà×ण¨dihydrouracil£©ÃüÃûµÄ¡£ $+[ v17lF  
×î³£¼ûµÄtRNA·Ö×ÓÓÐ76¸ö¼î»ù£¬Ïà¶Ô·Ö×ÓÖÊÁ¿Ô¼Îª2.5¡Á104¡£²»Í¬µÄtRNA·Ö×Ó¿ÉÓÐ74-95¸öºËÜÕËá²»µÈ£¬tRNA·Ö×Ó³¤¶ÈµÄ²»Í¬Ö÷ÒªÊÇÓÉÆäÖеÄÁ½ÌõÊÖ±ÛÒýÆðµÄ¡£tRNAµÄÏ¡Óмî»ùº¬Á¿·Ç³£·á¸»£¬Ô¼ÓÐ70ÓàÖÖ¡£Ã¿¸ötRNA·Ö×ÓÖÁÉÙº¬ÓÐ2¸öÏ¡Óмî»ù£¬×î¶àÓÐ19¸ö£¬¶àÊý·Ö²¼ÔÚ·ÇÅä¶ÔÇø£¬ÌرðÊÇÔÚ·´ÃÜÂë×Ó3¡¯¶ËÁÚ½ü²¿Î»³öÏÖµÄƵÂÊ×î¸ß£¬ÇÒ´ó¶àΪàÑßʺËÜÕËá¡£Õâ¶ÔÓÚά³Ö·´ÃÜÂë×Ó»·µÄÎȶ¨ÐÔ¼°ÃÜÂë×Ó¡¢·´ÃÜÂë×ÓÖ®¼äµÄÅä¶ÔÊǺÜÖØÒªµÄ¡£ 2xpI|+ a%  
2£®tRNAµÄLÐÎÈý¼¶½á¹¹ hW-?j&yJ?  
½ÍĸºÍ´ó³¦¸Ë¾útRNAµÄÈý¼¶½á¹¹¶¼³ÊLÐÎÕÛµþʽ¡£ÕâÖֽṹÊÇ¿¿Çâ¼üÀ´Î¬³ÖµÄ£¬tRNAµÄÈý¼¶½á¹¹ÓëAA- tRNAºÏ³ÉøµÄʶ±ðÓйء£ÊÜÌå±ÛºÍT¦ÕC±ÛµÄ¸Ë×´ÇøÓò¹¹³ÉÁ˵ÚÒ»¸öË«ÂÝÐý£¬D±ÛºÍ·´ÃÜÂë×ӱ۵ĸË×´ÇøÓòÐγÉÁ˵ڶþ¸öË«ÂÝÐý¡£ kt hy9<!$  
tRNAµÄLÐθ߼¶½á¹¹·´Ó³ÁËÆäÉúÎïѧ¹¦ÄÜ£¬ÒòΪËüÉÏËùÔËÔصݱ»ùËá±ØÐë¿¿½üλÓÚºËÌÇÌå´óÑÇ»ùÉϵĶàëĺϳÉλµã£¬¶øËüµÄ·´ÃÜÂë×Ó±ØÐëÓëСÑÇ»ùÉϵÄmRNAÏàÅä¶Ô£¬ËùÒÔÁ½¸ö²»Í¬µÄ¹¦ÄÜ»ùÍÅ×î´óÏ޶ȷÖÀë¡£ -f8iq[F5  
3£®tRNAµÄ¹¦ÄÜ >iI-Cs7TD  
ת¼¹ý³ÌÊÇÐÅÏ¢´ÓÒ»ÖÖºËËá·Ö×Ó£¨DNA£©×ªÒÆÖÁÁíÒ»ÖֽṹÉϼ«ÎªÏàËƵĺËËá·Ö×Ó£¨RNA£©µÄ¹ý³Ì£¬ÐÅϢתÒÆ¿¿µÄÊǼî»ùÅä¶Ô¡£·­Òë½×¶ÎÒÅ´«ÐÅÏ¢´ÓmRNA·Ö×ÓתÒƵ½½á¹¹¼«²»ÏàͬµÄµ°°×ÖÊ·Ö×Ó£¬ÐÅÏ¢ÊÇÒÔÄܱ»·­Òë³Éµ¥¸ö°±»ùËáµÄÈýÁª×ÓÃÜÂëÐÎʽ´æÔڵģ¬ÔÚÕâÀïÆð×÷ÓõÄÊǽâÂë»úÖÆ¡£ ,9~2#[|lq  
4£®tRNAµÄÖÖÀà :0j_I\L  
£¨1£©ÆðʼtRNAºÍÑÓÉìtRNA .L}k-8  
ÄÜÌØÒìµØʶ±ðmRNAÄ£°åÉÏÆðʼÃÜÂë×ÓµÄtRNA½ÐÆðʼtRNA£¬ÆäËûtRNAͳ³ÆΪÑÓÉìtRNA¡£Ô­ºËÉúÎïÆðʼtRNAЯ´ø¼×õ£¼×Áò°±ËᣨfMet£©£¬ÕæºËÉúÎïÆðʼtRNAЯ´ø¼×Áò°±ËᣨMet£©¡£ 6^"Spf]  
£¨2£©Í¬¹¤tRNA _air'XQ&!  
´ú±íͬһÖÖ°±»ùËáµÄtRNA³ÆΪͬ¹¤tRNA£¬Í¬¹¤tRNA¼ÈÒªÓв»Í¬µÄ·´ÃÜÂë×ÓÒÔʶ±ð¸Ã°±»ùËáµÄ¸÷ÖÖͬÒåÃÜÂ룬ÓÖÒªÓÐijÖֽṹÉϵĹ²Í¬ÐÔ£¬Äܱ»AA- tRNAºÏ³Éøʶ±ð¡£ ]F*fQ Ncjy  
£¨3£©Ð£ÕýtRNA B)u*c]<qU  
УÕýtRNA·ÖΪÎÞÒåÍ»±ä¼°´íÒåÍ»±äУÕý¡£ 8~8VoU&  
ÔÚµ°°×ÖʵĽṹ»ùÒòÖУ¬Ò»¸öºËÜÕËáµÄ¸Ä±ä¿ÉÄÜʹ´ú±íij¸ö°±»ùËáµÄÃÜÂë×Ó±ä³ÉÖÕÖ¹ÃÜÂë×Ó£¨UAG¡¢UGA¡¢UAA£©£¬Ê¹µ°°×ÖʺϳÉÌáÇ°ÖÕÖ¹£¬ºÏ³ÉÎÞ¹¦ÄܵĻòÎÞÒâÒåµÄ¶àëÄ£¬ÕâÖÖÍ»±ä¾Í³ÆΪÎÞÒåÍ»±ä¡£ Ex}hk!  
h_K!ch }  
Î壮AA- tRNAºÏ³Éø ÊÇÒ»Àà´ß»¯°±»ùËáÓëtRNA½áºÏµÄÌØÒìÐÔø£¬Æ䷴ӦʽÈçÏ£º h7F5-~SpD  
Ëüʵ¼ÊÉÏ°üÀ¨Á½²½·´Ó¦£º QlK]2r9  
µÚÒ»²½ÊÇ°±»ùËá»î»¯Éú³Éø-°±»ùõ£ÏÙÜÕËḴºÏÎï¡£ :c`Gh< u  
AA+ATP+ø£¨E£©¡úE-AA-AMP+PPi S;I}:F#5  
µÚ¶þ²½ÊÇ°±õ£»ùתÒƵ½tRNA 3¡¯Ä©¶ËÏÙÜղлùÉÏ£¬ÓëÆä2¡¯»ò3¡¯-ôÇ»ù½áºÏ¡£ QL`Hb p  
E-AA-AMP+ tRNA¡úAA- tRNA +E+AMP tkKiuh?m  
µ°°×ÖʺϳɵÄÕæʵÐÔÖ÷Òª¾ö¶¨ÓÚAA- tRNAºÏ³ÉøÊÇ·ñÄÜʹ°±»ùËáÓë¶ÔÓ¦µÄtRNAÏà½áºÏ¡£AA-tRNAºÏ³Éø¼ÈÒªÄÜʶ±ðtRNA£¬ÓÖÒªÄÜʶ±ð°±»ùËᣬËü¶ÔÁ½Õ߶¼¾ßÓи߶ȵÄרһÐÔ¡£²»Í¬µÄtRNAÓв»Í¬¼î»ù×é³ÉºÍ¿Õ¼ä½á¹¹£¬ÈÝÒ×±»tRNAºÏ³ÉøËùʶ±ð£¬À§ÄѵÄÊÇÕâЩøÈçºÎʶ±ð½á¹¹ÉϷdz£ÏàËƵݱ»ùËá¡£ {E$smX  
ÓÐÁ½µÀ¹Ø¿Ú: cCbZ*  
The first filter is the initial binding of the amino acid to the enzyme and its activation to aminoacyl-AMP. 7Nt6}${=z  
The second filter is the binding of incorrect aminoacyl-AMP products to a separate active site on the enzyme. )>U7+ Me  
EK$3T5e  
ºËÌÇÌåÏñÒ»¸öÄÜÑØmRNAÄ£°åÒƶ¯µÄ¹¤³§£¬Ö´ÐÐ×ŵ°°×ÖʺϳɵŦÄÜ¡£ËüÊÇÓɼ¸Ê®ÖÖµ°°×Öʺͼ¸ÖÖºËÌÇÌåRNA£¨ribosomal RNA£¬rRNA£©×é³ÉµÄÑÇϸ°û¿ÅÁ£¡£Ò»¸öϸ¾úϸ°ûÄÚÔ¼ÓÐ20000¸öºËÌÇÌ壬¶øÕæºËϸ°ûÄÚ¿É´ï106¸ö£¬ÔÚδ³ÉÊìµÄó¸òÜÂÑϸ°ûÄÚÔò¸ß´ï1012¡£ºËÌÇÌåºÍËüµÄ¸¨ÖúÒò×ÓΪµ°°×ÖʺϳÉÌṩÁ˱ØÒªÌõ¼þ¡£ 8zzY;3^h;  
2*ByVK  
1.ºËÌÇÌåµÄ×é³É B6xM#)  
Ô­ºËÉúÎïºËÌÇÌåÓÉÔ¼2/3µÄRNA¼°1/3µÄµ°°×ÖÊ×é³É¡£ÕæºËÉúÎïºËÌÇÌåÖÐRNAÕ¼3/5£¬µ°°×ÖÊÕ¼2/5¡£ºËÌÇÌåÊÇÒ»¸öÖÂÃܵĺËÌǺ˵°°×¿ÅÁ££¬¿ÉÒÔ½âÀëΪÁ½¸öÑÇ»ù£¬Ã¿¸öÑÇ»ù¶¼º¬ÓÐÒ»¸öÏà¶Ô·Ö×ÓÖÊÁ¿½Ï´óµÄrRNAºÍÐí¶à²»Í¬µÄµ°°×ÖÊ·Ö×Ó¡£ i-gN< 8\v  
´ó³¦¸Ë¾úºËÌÇÌåСÑÇ»ùÓÉ21ÖÖµ°°×ÖÊ×é³É£¬·Ö±ðÓÃS1¡­¡­S21±íʾ£¬´óÑÇ»ùÓÉ33ÖÖµ°°×ÖÊ×é³É£¬·Ö±ðÓÃL1¡­¡­L33±íʾ¡£ÕæºËÉúÎïϸ°ûºËÌÇÌå´óÑÇ»ùº¬ÓÐ49ÖÖµ°°×ÖÊ£¬Ð¡ÑÇ»ùÓÐ33ÖÖµ°°×ÖÊ¡£ 5V@c~ 1\  
2¡¢rRNA u@pimRVo  
3.ºËÌÇÌåµÄ¹¦ÄÜ Lv m"!!  
ºËÌÇÌå°üÀ¨ÖÁÉÙ5¸ö»îÐÔÖÐÐÄ£¬¼´mRNA½áºÏ²¿Î»¡¢½áºÏ»ò½ÓÊÜAA- tRNA²¿Î»£¨A룩¡¢½áºÏ»ò½ÓÊÜëÄ»ùtRNAµÄ²¿Î»¡¢ëÄ»ùתÒƲ¿Î»£¨P룩¼°ÐγÉëļüµÄ²¿Î»£¨×ªëÄøÖÐÐÄ£©£¬´ËÍ⻹ÓиºÔðëÄÁ´ÑÓÉìµÄ¸÷ÖÖÑÓÉìÒò×ӵĽáºÏλµã¡£Ð¡ÑÇ»ùÉÏÓµÓÐmRNA½áºÏλµã£¬¸ºÔð¶ÔÐòÁÐÌØÒìµÄʶ±ð¹ý³Ì£¬ÈçÆðʼλµãµÄʶ±ðºÍÃÜÂë×ÓÓë·´ÃÜÂë×ÓµÄÏ໥×÷ÓᣴóÑÇ»ù¸ºÔð°±»ùËá¼°tRNAЯ´øµÄ¹¦ÄÜ£¬ÈçëļüµÄÐγɡ¢AA- tRNA¡¢ëÄ»ù- tRNAµÄ½áºÏµÈ¡£Aλ¡¢Pλ¡¢×ªëÄøÖÐÐĵÈÖ÷ÒªÔÚ´óÑÇ»ùÉÏ¡£ :B  9>  
ºËÌÇÌå¿É½âÀëΪÑÇ»ù»ò½áºÏ³É70S/80S¿ÅÁ£¡£·­ÒëµÄÆðʼ½×¶ÎÐèÒªÓÎÀëµÄÑÇ»ù£¬Ëæºó²Å½áºÏ³É70S/80S¿ÅÁ££¬¼ÌÐø·­Òë½ø³Ì¡£ÌåÍâ·´Ó¦ÌåϵÖУ¬ºËÌÇÌåµÄ½âÀë»ò½áºÏÈ¡¾öÓÚMg2+Àë×ÓŨ¶È¡£Ôڴ󳦸˾úÄÚ£¬Mg2+Ũ¶ÈÔÚ10-3mol/LÒÔÏÂʱ£¬70S½âÀëΪÑÇ»ù£¬Å¨¶È´ï10-2mol/LʱÔòÐγÉÎȶ¨µÄ70S¿ÅÁ£¡£Ï¸°ûÖдó¶àÊýºËÌÇÌå´¦ÓÚ·Ç»îÐÔµÄÎȶ¨×´Ì¬£¬µ¥¶À´æÔÚ£¬Ö»ÓÐÉÙÊýÓëmRNAÒ»ÆðÐγɶà¾ÛºËÌÇÌå¡£Ëü´ÓmRNAµÄ5¡¯Ä©¶ËÏò3¡¯Ä©¶ËÔĶÁÃÜÂë×Ó£¬ÖÁÖÕÖ¹×ÓʱºÏ³ÉÒ»ÌõÍêÕûµÄ¶àëÄÁ´¡£mRNAÉϺËÌÇÌåµÄ¶àÉÙÊÓmRNAµÄ³¤¶Ì¶ø¶¨£¬Ò»°ã40¸öºËÜÕËáÓÐÒ»¸öºËÌÇÌå¡£ ;Bwg'ThT  
rc`}QoB)R  
Æß. ÐÅʹºËÌǺËËá jiqE^j3;  
mRNA messenger ribonucleic acidDNA deoxyribonucleic acid. Z|$M 9E  
ËäÈ»mRNAÔÚËùÓÐϸ°ûÄÚÖ´ÐÐ×ÅÏàͬµÄ¹¦ÄÜ£¬¼´Í¨¹ýÈýÁª×ÓÃÜÂë·­ÒëÉú³Éµ°°×ÖÊ£¬ÆäÉúÎïºÏ³ÉµÄ¾ßÌå¹ý³ÌºÍ³ÉÊìmRNAµÄ½á¹¹ÔÚÔ­ºËºÍÕæºËÉúÎïϸ°ûÄÚÊDz»Í¬µÄ¡£ y$[:Kh,  
 HvzXAd  
°Ë¡¢µ°°×ÖʵÄÉúÎïºÏ³É W!t=9i  
ºËÌÇÌåÊǵ°°×Öʺϳɵij¡Ëù£¬mRNAÊǵ°°×ÖʺϳɵÄÄ£°å£¬tRNAÊÇÄ£°åÓë°±»ùËáÖ®¼äµÄ½ÓºÏÌå¡£´ËÍ⣬ÓÐ20ÖÖÒÔÉϵÄAA-tRNA¼°ºÏ³Éø¡¢10¶àÖÖÆðʼÒò×Ó¡¢ÑÓÉìÒò×Ó¼°ÖÕÖ¹Òò×Ó£¬30¶àÖÖtRNA¼°¸÷ÖÖrRNA¡¢mRNAºÍ100ÖÖÒÔÉÏ·­Òëºó¼Ó¹¤Ã¸²ÎÓëµ°°×Öʺϳɺͼӹ¤¹ý³Ì¡£ #Ic)]0L  
µ°°×ÖʺϳÉÏûºÄÁËϸ°ûÖÐ90%×óÓÒÓÃÓÚÉúÎïºÏ³É·´Ó¦µÄÄÜÁ¿¡£Ï¸¾úϸ°ûÖеÄ2Íò¸öºËÌÇÌ壬10Íò¸öµ°°×ÖÊÒò×ÓºÍ20Íò¸ötRNAs Ô¼Õ¼´ó³¦¸Ë¾ú¸ÉÖصÄ35%¡£ bYAtUEv  
Ôڴ󳦸˾úÖкϳÉÒ»¸ö100¸ö°±»ùËáµÄ¶àëÄÖ»Ðè5·ÖÖÓ¡£ b|oT!s  
2mEvoWnJ  
1.µ°°×ÖÊÉúÎïºÏ³ÉµÄÖ÷Òª²½Ö裺 cp$GP*{@  
·­ÒëµÄÆðʼ¡ª¡ªºËÌÇÌåÓëmRNA½áºÏ²¢Óë°±»ùõ£-tRNAÉú³ÉÆðʼ¸´ºÏÎï¡£ëÄÁ´µÄÑÓÉ졪¡ªºËÌÇÌåÑØmRNA5¡¯¶ËÏò3¡¯¶ËÒƶ¯£¬µ¼Ö´ÓN¶ËÏòC¶ËµÄ¶àëĺϳɡ£ëÄÁ´µÄÖÕÖ¹ÒÔ¼°ëÄÁ´µÄÊÍ·Å¡ª¡ªºËÌÇÌå´ÓmRNAÉϽâÀ룬׼±¸ÐÂÒ»Âֺϳɷ´Ó¦¡£ /odDJxJ k  
Ö÷Òª·ÖΪÎå²½ W`v$-o-  
1¡¢ Activation of Amino Acids (This reaction takes place in the cytosol, not on the ribosome). 5D eo}(3  
2¡¢ Initiation. The mRNA bearing the code for the polypeptide binds to the small ribosomal subunit and to the initiating aminoacyl-tRNA. Hg5 :>?Lw@  
3¡¢Elongation. Peptide bonds are formed in this stage. Z@,[a  
4¡¢Termination and Release. Completion of the polypeptide chain is signaled by a termination codon in the mRNA. ,0a\Ka {^  
5¡¢Folding and Post translational Processing. Kv9Z.DY  
ëÄÁ´ÑÓÉì·ÖΪÈý²½ V:h7}T95  
¢Ù Binding of an incoming aminoacyl-tRNA. %'OY  
¢Ú Peptide bond formation. s@IgaF {  
¢Û Translocation. Xz`0nU  
i&YWutG  
2.Óëµ°°×ÖʺϳÉÓйصÄÒò×Ó % :h %i|  
ÆðʼÒò×ÓInitiation factor£¨IF£©ÑÓÉìÒò×ÓElongation factor£¨EF£©ÖÕÖ¹Òò×Ó¡£Ô­ºËÖÐÓÐRF1-3¡£RF-1 ʶ±ð UAAºÍUAG; RF-2 ʶ±ð UAAºÍUGA; RF-3 ½öÄÜ´Ù½øRF-1ºÍRF-2µÄ¹¦ÄÜ¡£ÖÕÖ¹Òò×ÓÐÐʹ¹¦ÄÜʱÐèÒªGTP¡£ÕæºËÉúÎïÖÐÖ»ÓÐÒ»¸öRF£¬ÄÜʶ±ð3¸öÖÕÖ¹×Ó¡£ -}_1f[b  
=;Dj[<mJ45  
3¡¢µ°°×ÖʺϳɵÄÆðʼ BU#3fPl  
µ°°×ÖʺϳɵÄÆðʼ¸´ºÏÎï: wJj:hA}  
30S ºËÌÇÌåСÑÇ»ù _iL?kf  
Ä£°åmRNA ;5DDV6  
fMet-tRNAfMet ;y_]w6|n  
ÆðʼÒò×Ó >x>/}`  
GTP LcZ|A;it  
50S ºËÌÇÌå´óÑÇ»ù .$@+ / @4  
Mg2+ Y_K W9T_  
ºÏ³ÉµÄÆðʼ¿É·ÖΪÈý²½: IC?(F]$%>  
1¡¢30S ºËÌÇÌåСÑÇ»ùÓëÆðʼÒò×ÓIF ¨C1ºÍIF-3Ïà½áºÏ£¬ÓÕ·¢Ä£°åmRNAÓëСÑÇ»ù½áºÏ¡£ Q':hmulT!  
2¡¢ÓÉ30S СÑÇ»ù¡¢ÆðʼÒò×ÓIF ¨C1ºÍIF-3¼°Ä£°åmRNAËù×é³ÉµÄ¸´ºÏÎïÁ¢¼´ÓëGTP-IF-2¼°fMet-tRNAfMetÏà½áºÏ¡£·´ÃÜÂë×ÓÓëÃÜÂë×ÓÅä¶Ô¡£ P ^ 4 @  
3¡¢ÉÏÊöÁù×é·Ö¸´ºÏÎïÔÙÓë50S´óÑÇ»ù½áºÏ£¬Ë®½âGTPÉú³É²¢ÊÍ·ÅGDPºÍPi¡£ÊÍ·ÅÈý¸öÆðʼÒò×Ó¡£ 3)y L#hXg)  
R0%M9;>1  
±í27-9 ÕæºËϸ°ûÖвÎÓë·­ÒëÆðʼµÄµ°°×ÖÊÒò×Ó¼°Æ书ÄÜ C]p@7"l  
HIt Nd  
ÕæºËÒò×Ó ¹¦ÄÜ <{GVA0nr  
eIF2 ´Ù½øMet-tRNAMetÓëºËÌÇÌå40SСÑÇ»ù½áºÏ¡£ w@<II-9L)<  
eIF2B Ek1c>s,t  
eIF3 { :1X N  
ÊÇ×îÔçÓëºËÌÇÌå40SСÑÇ»ù½áºÏµÄ´Ù½øÒò×Ó£¬µ°°×Öʺϳɷ´Ó¦µÄÕý³£½øÐС£ Qe{w)e0}`  
eIF4A ¾ßÓÐRNA½âÐýø»îÐÔ£¬½â³ýmRNAÄ£°åµÄ´Î¼¶½á¹¹²¢Ê¹Ö®Óë40SСÑÇ»ù½áºÏ£¬ÐγÉeIF4F¸´ºÏÎï¡£ z$WLx  
eIF4B ÓëmRNAÄ£°åÏà½áºÏ£¬Ð­ÖúºËÌÇÌåɨÃèÄ£°åÐòÁУ¬¶¨Î»AUG¡£ fjOq@thD  
eIF4E ÓëmRNA 5¡¯µÄñ×ӽṹÏà½áºÏ£¬ÐγÉeIF4F¸´ºÏÎï¡£ a ydNSgu  
eIF4G ÓëeIF4EºÍpoly£¨A£©½áºÏµ°°×£¨PAB£©Ïà½áºÏ£¬ÐγÉeIF4F¸´ºÏÎï¡£ GX0zirz  
eIF5 ´Ùʹ¶à¸öµ°°×Òò×ÓÓë40SСÑÇ»ù½âÌ壬ÒÔ´Ë°ïÖú´óСÑÇ»ù½áºÏÐγÉ80ºËÌÇÌ壬Ðγɷ­ÒëÆðʼ¸´ºÏÎï¡£ "?.#z]']  
eIF6 ´Ù½øûÓе°°×ÖʺϳɻîÐÔµÄ80SºËÌÇÌå½âÀë³É40SºÍ60SÁ½¸öÑÇ»ù¡£ Z XGi> E  
S>r",S  
¡¡4¡¢ëÄÁ´µÄÑÓÉì 9 @xl{S-  
ëÄÁ´ÑÓÉìµÄ»ù±¾ÒªÇóÊÇ £º X fqhD&g  
ÓÐÍêÕûµÄÆðʼ¸´ºÏÎ bi^?SH\  
Óа±»ùõ£-tRNA£¬ X.#)CB0c1Q  
ÓÐÑÓÉìÒò×ÓEF-Tu, EF-TsºÍEF-G£¬ Id##367R  
ÓÐGTP¡£ [ r8 ZAS  
q;")  
ëÄÁ´ÑÓÉìÒ²¿É±»·ÖΪÈý²½£º hd u2?v@  
µÚÒ»²½£¬ÓëнøÀ´µÄ°±»ùõ£-tRNAÏà½áºÏ¡£°±»ùõ£-tRNAÊ×ÏȱØÐëÓëGTP-EF-Tu¸´ºÏÎïÏà½áºÏ£¬Ðγɰ±»ùõ£-tRNA-GTP-EF-Tu¸´ºÏÎï²¢Óë70SÖеÄAλµãÏà½áºÏ¡£´Ëʱ£¬GTPË®½â²¢ÊÍ·ÅGDP-EF-Tu¸´ºÏÎï¡£ f+Sb> $  
µÚ¶þ²½£¬ëļüÐγɡ£ ëļüÐγÉÖ®³õ£¬Á½¸ö°±»ùËáÈÔÈ»·Ö±ðÓë¸÷×ÔµÄtRNAÏà½áºÏ£¬ÈÔÈ»·Ö±ðλÓÚAλµãºÍPλµãÉÏ¡£AλµãÉϵݱ»ùËᣨµÚ¶þ¸ö°±»ùËᣩÖеĦÁ-°±»ù×÷ΪÇ׺˻ùÍÅÈ¡´úÁËPλµãÉϵÄtRNA£¬²¢ÓëÆðʼ°±»ùËáÖеÄCOOH»ùÍÅÐγÉëļü¡£±¾·´Ó¦¿ÉÄÜÓÉpeptidyl transferase ´ß»¯¡£ EgU#r@7I  
µÚÈý²½£¬ÒÆ루translocation£©¡£ ºËÌÇÌåÏòmRNAµÄ3¡¯·½ÏòÒƶ¯Ò»¸öÃÜÂë×Ó£¬Ê¹µÃ´øÓеڶþ¸ö°±»ùËᣨÏÖÒѳÉΪ¶þëÄ£©µÄtRNA´ÓAλ½øÈëP룬²¢Ê¹µÚÒ»¸ötRNA´ÓPλ½øÈëEλ¡£´Ëʱģ°åÉϵĵÚÈý¸öÃÜÂë×ÓÕýºÃÔÚAλÉÏ¡£ºËÌÇÌåµÄÒÆλÐèÒªEF-G£¨translocase£©ºÍÁíÒ»·Ö×ÓGTPË®½âÌṩÄÜÁ¿¡£ V@!)Pw  
hg(<>_~  
5¡¢ëÄÁ´µÄÖÕÖ¹ 3_~iq>l  
µ±ÖÕÖ¹ÃÜÂë×Ó½øÈëºËÌÇÌåAλµãʱ£¬ÔÚÊÍ·ÅÒò×ÓRF1-3µÄ×÷ÓÃÏ£º c&!mKMrk  
£¨1£©Ë®½âÄ©¶ËëÄ»ùtRNA£» o[T+/Ej&  
£¨2£©ÊÍ·ÅÐÂÉúëĺÍtRNA£» &J*M  
£¨3£©Ê¹70SºËÌÇÌå½âÀë³É30SºÍ50SÁ½¸öÑÇ»ù¡£ 1J4Pnl+hN  
jk{(o09  
6¡¢µ°°×ÖʺϳɵÄÒÖÖƼÁ w_xca(  
¿¹¾úËضԵ°°×ÖʺϳɵÄ×÷ÓÿÉÄÜÊÇ×èÖ¹mRNAÓëºËÌÇÌå½áºÏ£¨ÂÈùËØ£©£¬»ò×èÖ¹AA-tRNAÓëºËÌÇÌå½áºÏ£¨ËÄ»·ËØÀࣩ£¬»ò¸ÉÈÅAA-tRNAÓëºËÌÇÌå½áºÏ¶ø²úÉú´í¶Á£¨Á´Ã¹ËØ¡¢ÐÂùËØ¡¢¿¨ÄÇùËصȣ©£¬»ò×÷Ϊ¾ºÕùÐÔÒÖÖƼÁÒÖÖƵ°°×Öʺϳɡ£ WXl+w7jr  
Á´Ã¹ËØÊÇÒ»ÖÖ¼îÐÔÈýÌÇ£¬¸ÉÈÅfMet-tRNAÓëºËÌÇÌåµÄ½áºÏ£¬´Ó¶ø×èÖ¹µ°°×ÖʺϳɵÄÕýÈ·Æðʼ£¬²¢µ¼ÖÂmRNAµÄ´í¶Á¡£ÈôÒÔpoly£¨U£©×÷Ä£°å£¬Ôò³ý±½±û°±ËᣨUUU£©Í⣬ÒìÁÁ°±ËᣨAUU£©Ò²»á²ôÈë¡£¶ÔÁ´Ã¹ËØÃô¸ÐλµãÔÚ30SÑÇ»ùÉÏ¡£ -juG[zn  
àÑßÊùËØÊÇAA-tRNAµÄ½á¹¹ÀàËÆÎÄܽáºÏÔÚºËÌÇÌåµÄAλÉÏ£¬ÒÖÖÆAA-tRNAµÄ½øÈë¡£ËüËù´øµÄ°±»ùÓëAA- tRNAÉϵݱ»ùÒ»Ñù£¬ÄÜÓëÉú³¤ÖÐëÄÁ´ÉϵÄôÈ»ùÉú³Éëļü£¬Õâ¸ö·´Ó¦µÄ²úÎïÊÇÒ»Ìõ3¡¯ôÈ»ù¶Ë¹ÒÁËÒ»àÑßÊùËØ¡£ .mt%8 GM  
ÇàùËØ¡¢ËÄ»·ËغͺìùËØÖ»ÓëÔ­ºËϸ°ûºËÌÇÌå·¢Éú×÷Ó㬴Ӷø×è¶ôÔ­ºËÉúÎïµ°°×Öʵĺϳɣ¬ÒÖÖÆϸ¾úÉú³¤¡£ÂÈùËغÍàÑßÊùËؼÈÄÜÓëÔ­ºËϸ°ûºËÌÇÌå½áºÏ£¬ÓÖÄÜÓëÕæºËÉúÎïºËÌÇÌå½áºÏ£¬·Á°­Ï¸°ûÄÚµ°°×Öʺϳɣ¬Ó°Ïìϸ°ûÉú³¤¡£Òò´Ë£¬Ç°3ÖÖ¿¹ÉúËر»¹ã·ºÓÃÓÚÈËÀàҽѧ£¬ºóÁ½ÖÖÔòºÜÉÙÔÚҽѧÉÏʹÓᣠeZLEdTScM  
by X!,  
--------------------------------------- >H!Mx_fDL  
^AS \a4`/  
µÚËĽ² DNA¡¢RNAºÍµ°°×ÖÊ´úл x i=ApwNj  
DNAÊÇÖü²ØÒÅ´«ÐÅÏ¢µÄ×îÖØÒªµÄÉúÎï´ó·Ö×Ó¡£DNA·Ö×ÓÖеĺËÜÕËáÅÅÁÐ˳Ðò²»µ«¾ö¶¨ÁË°ûÄÚËùÓÐRNA¼°µ°°×ÖʵĻù±¾½á¹¹£¬»¹Í¨¹ýµ°°×ÖÊ£¨Ã¸£©µÄ¹¦Äܼä½Ó¿ØÖÆÁËϸ°ûÄÚÈ«²¿ÓÐЧ³É·ÝµÄÉú²ú¡¢ÔËתºÍ¹¦ÄÜ·¢»Ó¡£Öü²ØÔÚÈκλùÒòÖеÄÉúÎïÐÅÏ¢¶¼±ØÐëÊ×Ïȱ»×ªÂ¼Éú³ÉRNA£¬²ÅÄܹ»µÃµ½±í´ï¡£DNAºÍRNAËäÈ»ºÜÏàËÆ£¬Ö»ÓÐT»òU¼°ºËÌǵĵڶþλ̼ԭ×ÓÉÏÓÐËù²»Í¬£¬µ«ËüÃǵÄÉúÎïѧ»îÐÔÈ´ºÜ²»Í¬¡£ iqQT ^  
RNAÖ÷ÒªÒÔµ¥Á´ÐÎʽ´æÔÚÓÚÉúÎïÌåÄÚ£¬Æä¸ß¼¶½á¹¹ºÜ¸´ÔÓ£»RNA¼Èµ£¸º×ÅÖü²Ø¼°×ªÒÆÒÅ´«ÐÅÏ¢µÄ¹¦ÄÜ£¬ÓÖÄÜ×÷ΪºËøֱ½ÓÔÚϸ°ûÄÚ·¢»Ó´úл¹¦ÄÜ¡£ .p&@;fZ  
'J|)4OG:  
µ°°×ÖÊÊÇÉúÎïÐÅϢͨ·ÉϵÄÖÕ²úÎһ¸ö»îϸ°ûÔÚÈκη¢Óý½×¶Î¶¼ÐèÒªÊýǧÖÖ²»Í¬µÄµ°°×ÖÊ¡£Òò´Ë£¬»îϸ°ûÄÚʱ¿Ì½øÐÐן÷ÖÖµ°°×Öʵĺϳɡ¢ÐÞÊΡ¢ÔËתºÍ½µ½â·´Ó¦¡£ //U1mDFT  
4^tSg#!V{  
Ò»¡¢ºËÜÕËáµÄºÏ³ÉÓë´úл t'rN7.d  
<U@N ^#  
ºËÜÕËáÊÇDNAºÍRNAµÄÇ°ÌåÊÇϸ°ûÄÚ»¯Ñ§ÄÜÁ÷ͨÁìÓòÖеÄÔØÌ壨ATP£¬ GTP£©,ÊÇNAD¡¢FAD¡¢S-adenosylmethionine¼° Coenzyme AµÈµÄÖØÒª³É·Ý¡£ÔÚÌÇ´úлÖÐÒ²ÓÐÖØÒª×÷Óã¬ÈçÉú³ÉUDPGºÍ CDP-diacylglycerolµÈ¡£cAMP, cGMP»¹ÊǵڶþÐÅʹ¡£ <+i(CGw  
 5&&4-  
1¡¢De NovoàÑßʺËÜÕËáµÄÉúÎïºÏ³ÉʼÓÚPRPP £¨Phosphoribosyl 1-pyrophosphate£© &X$T "Dp  
IOcQI:4.`  
Õâһ;¾¶µÄµÚÒ»²½ÊÇÓɹȰ±õ£°·¾èÏ×Ò»¸ö°±»ùµ½PRPPµÄC-1λÉÏ£¬Éú³É5-phosphoribosylamine¡£  `Vb  
Æä´Î£¬°Ñ¸Ê°±ËáÖеÄÈý¸ö»ùÍżӵ½PRAÉÏ¡£ {LO Pm1K8Y  
µÚÈý£¬ÓÉN10-¼×»ùËÄÇâÒ¶ËáÌṩһ¸ö¼×»ù¡£ ?Z7`TnG$uf  
µÚËÄ£¬¹È°±õ£°·ÌṩÁíÒ»¸öN¡£ bbK};u  
µÚÎ壬ÍÑË®»·»¯ÐγÉßäßò»·¡£ = xO03|T;6  
µÚÁù£¬ôÈ»ù»¯ <'a~Y3B"o  
µÚÆߣ¬Í¨¹ý·Ö×ÓÖØÅŽ«ôÈ»ù´ÓßäßòµÚ4̼µÄ»·Íâ°±»ùÉÏתÒƵ½µÚ5λ̼ԭ×ÓÉÏ¡£  EKwQ$?I  
µÚ°Ë-¾Å£¬ÓÉÌìÃŶ¬õ£°·°ÑÁíÒ»¸ö°±»ù¼Óµ½µÚ5λ̼ԭ×ÓÉÏ¡£ K4c:k; V  
µÚÊ®£¬ÔÙÓÉN10-¼×»ùËÄÇâÒ¶ËáÌṩһ¸ö¼×»ù¡£ b(H{i}{]  
µÚʮһ£¬ÍÑË®»·»¯£¬ÐγÉàÑßÊIMP¡£ Dqx#i-L23  
KA5)]UF`l  
²ÎÓëºÏ³ÉAMPµÄÊÇ¢ÙÏÙÜÕçúçêËáºÏ³ÉøºÍ¢ÚÏÙÜÕçúçêËáÁѽâø¡£ iC gZ3M]  
²ÎÓëºÏ³ÉGMPµÄÊÇ¢ÛIMPÍÑÇâøºÍ¢ÜXMP-¹È°±õ£°·õ£°·×ªÒÆø ¡£ &L ;ocd$  
-@W9+Zf5  
2. àÑßʺËÜÕËáºÏ³ÉÖеķ´À¡µ÷½Ú Td=4V,BN  
3£®à×ऺËÜÕËáÊÇÓÉÌìÃŶ¬õ£°·¡¢ PRPPºÍ°±»ù¼×õ£Á×ËáµÈ¹²Í¬ÐÎ³ÉµÄ (#Y~z',I  
 [XfR`@  
à×ऴÓÍ·ºÏ³É;¾¶²»Í¬ÓÚàÑßʵĺϳɣ¬6-Ô­×Óà×ऻ·Ê×Ïȱ»ºÏ³É£¬È»ºó²ÅÓëºËÌÇ-5-Á×ËáÏàÁ¬¡£Õâ¸ö·´Ó¦ÐèÒª°±»ù¼×õ£Á×ËᣨCarbamoyl phosphate£©¡£ _ 4ag- '5  
4£®ºËÜÕµ¥Á×Ëáת»¯ÎªºËÜÕÈýÁ×Ëá X z+%Ym  
·´Ó¦Éú³ÉµÄADP¿Éͨ¹ýÌǽͽâø»òÑõ»¯Á×Ëữ;¾¶±»½øÒ»²½Á×Ëữ¡£ rf.pT+g.P  
ATPÄܹ»°ÑÁ×Ëá»ùÍżӵ½ÆäËüËùÓкËÜÕµ¥Á×ËáÉÏÉú³ÉºËÜÕÈýÁ×Ëá¡£ p4' .1.@  
ºËÜÕ¶þÁ×Ëá¿Éͨ¹ýÒ»¸ö¹«ÓõĺËÜÕ¶þÁ×Ëἤø±»½øÒ»²½Á×ËữÉú³ÉºËÜÕÈýÁ×Ëá¡£ I C`3%^  
5£®ºËÌǺËÜÕËᣨribonucleotides£©ÊÇÍÑÑõºËÌǺËÜÕËᣨDeoxyribonucleotides£©µÄÇ°Ìå¡£ËùÓÐdNTP¶¼Ö±½ÓÀ´×ÔÓÚNTP£¨ÆäʵÊÇNDP£©¡£Õâ¸ö·´Ó¦ºÜÌØÊ⣬ÒòΪºËÌÇÉϵĻ¹Ô­·´Ó¦·¢ÉúÓÚÒ»¸öûÓлµÄ̼ԭ×ÓÉÏ¡£´ß»¯¸Ã·´Ó¦µÄøÊǺËÌǺËÜÕËỹԭø¡£ o.+;]i}D  
´ó³¦¸Ë¾úºËÜÕËỹԭøÓÐÁ½´óÌØÕ÷£¬ËüµÄÉúÎïѧ»îÐԺ͵×ÎïÌØÒìÐÔͬʱÊÜЧӦ×Ó£¨effector molecules£©µÄÓ°Ï졣ÿ¸öR1ÑÇ»ùÉ϶¼ÓÐÁ½¸öµ÷½Úλµã£¬µ±Ó°ÏìÕûÌåø»îÐÔµÄÄǸöλµãÓëATPÏà½áºÏʱ£¬Ã¸»îÐÔÔö¼Ó£»¶øµ±ËüÓëdATP½áºÏʱ£¬Ã¸»îÐÔÏûʧ¡£ ^9g$/8[^c_  
µÚ¶þ¸öµ÷½Úλµã¿ØÖÆÁ˵×ÎïÌØÒìÐÔ¡£µ±dATPÓë¸ÃλµãÏà½áºÏʱ£¬UDPºÍCDPµÄ»¹Ô­·´Ó¦ÓÅÏȽøÐС£µ±dTTPÓë¸ÃλµãÏà½áºÏʱ£¬GDPµÄ»¹Ô­·´Ó¦ÓÅÏȽøÐС£ 9 BCW2@Kp  
ºËÌǺËÜÕËỹԭ·´Ó¦µÄÖ÷Òª¹ý³Ì C"{^wy{sL  
1. »¹Ô­Ã¸R2ÑÇ»ù´¦ÓÚÑõ»¯Ì¬-X¨B£¬ÏòºËÌÇ3¡¯Î»Ì¼Ô­×ÓÉϵÄH·¢Æð¹¥»÷£¬Éú³É3¡¯Î»×ÔÓÉ»ù¡£ p8 rh`7  
2. R1ÑÇ»ùÉϵÄ-SH»ùÍÅΪ2¡¯-OHÌṩһ¸öHÔ­×Ó£¬Ê¹Ö®Éú³É-OH2»ùÍÅ¡£ tcD7OC:" 6  
3. ÍÑË®ºó£¬3¡¯Î»×ÔÓÉ»ù°ïÖúά³Ö2¡¯Î»O+»ùÍÅ¡£ b+rxin".  
4. R1ÑÇ»ùÉϵÄÁíÒ»¸ö-SH»ùÍÅΪ2¡¯-CH+Ìṩһ¸öHÔ­×Ó N'Gq9A  
5. 2¡¯ÉϵÄC¨B-OHÏòR2ÑÇ»ùÉϵÄX-H·¢Æð¹¥»÷¡£ /x<g$!`X  
6. 2¡¯ÉϵÄC-OHʧȥÑõÔ­×Ó£¬Éú³ÉdNDP¡£ÆäÖУ¬dTMP£¨thymidylate£©À´×ÔÓÚdCDPºÍdUMP£¬ÆäÖ±½ÓÇ°ÌåÊÇdUMP£¬ÓÉÐØÜÕËáºÏø£¨thymidylate synthase£©½«dUMPת»¯ÎªdTMP£»·´Ó¦Öеļ׻ùÀ´×ÔÓÚN5£¬N10-Methylene-tetrahydrofolate¡£ 44]s`QyG  
7¡¢àÑßʺÍà×ऽµ½âºó·Ö±ðÉú³ÉUric AcidºÍUrea¡£ JzyCeM =  
àÑßʺËÜÕËá½µ½â [GwAm>k  
µÚÒ»²½ÊÇÔÚ5¡¯-ºËÜÕËáø£¨5¡¯-nucleotidase£©µÄ×÷ÓÃÏÂÏûÈ¥Á×Ëá»ùÍÅ£¬ÓÉAdenosine-monophosphate±ä³ÉAdenosine£¬»ò´ÓGMP±ä³ÉGuanosine¡£ aO6\ e>  
¶þ¡¢ÔÚAdenosine deaminaseµÄ×÷ÓÃÏÂÉú³ÉInosine£» ,+=9Rp`md  
Èý¡¢ÔÚnucleosidaseµÄ×÷ÓÃÏÂÉú³ÉHypoxanthine»òÓÉGuanosineÉú³ÉGuanine£» eV;r /4  
ËÄ¡¢ÔÚXanthine oxidase»òGuanine deaminase×÷ÓÃÏÂÉú³ÉXanthine£» {15j'Qwm  
Îå¡¢ÔÚXanthine oxidaseµÄ×÷ÓÃÏÂÉú³ÉUric acid¡£ =Tj{)=^/#  
àÑßÊ´úлͻ±ä»áÒýÆðÖØÒª¼²²¡¡£ "F F$Q#)  
ÈçÈËÌåÄÚȱʧadenosine deaminase£¬»áÒý·¢ÑÏÖصÄÃâÒßȱʧÐÔ¼²²¡£¬ÒòΪ´ËʱT-ÁܰͺÍB-ÁÜ°Íϸ°û²»ÄÜÕý³£·¢Óý¡£ADȱʧºó£¬Ï¸°ûÄÚdATPµÄº¬Á¿½«¸ß´ïÕý³£Ï¸°ûÖеÄ100±¶£¬¶ø¹ýÁ¿µÄdATPÔòÒÖÖÆÁËÆäÓàdNTPÔÚT-ÁÜ°Íϸ°ûÖеĺϳɡ£Ðí¶à»¯ÁÆ£¨chemotherapy£©Ò©¼Á¶¼Õë¶ÔºËÜÕËáºÏ³É;¾¶¡£ÈçAzaserineºÍAcivicin¶¼ÊÇGlutamineÀàËÆÎ±»ÓÃÓÚ×è¶ÏºËÜÕËáµÄÉúÎïºÏ³É¡£ XlmX3RU  
n zq   
ÐØÜպϳÉÖеÄÖ÷ÒªÒÖÖƼÁÓÐfluorouracil£¨·úë壩¡¢methotrexate£¨°±¼×»ùÒ¶ËᣩºÍaminopterin£¨°±à©ßÊ£©¡£·úëå±¾Éí²»ÊÇthymidylate synthase ÒÖÖƼÁ£¬µ«ËüÔÚϸ°ûÖб»×ª»¯ÎªFdUMPÒԺ󣬾ÍÄÜÖ±½ÓÓëTSÏà½áºÏ²¢Ê¹Ö®Ê§»î¡£°±¼×»ùÒ¶ËáºÍ°±à©ßʶ¼ÊÇdihydrofolate reductaseµÄÒÖÖƼÁ£¬°±¼×»ùÒ¶ËáÓë¸ÃøµÄÇ׺ÍÁ¦±Èµ×Îïdihydrofolate¸ß100±¶¡£ !8{ VLg  
w^yb`\$  
¶þ¡¢°±»ùËá´úл tpfgUZ{  
°´ËùÕ¼µÄÖÊÁ¿±ÈÀý¼ÆË㣬NÔÚÉúÎïÌåÄÚµÄÖØÒªÐÔÅÅÔÚCHOÖ®ºó£¬ÁеÚ4λ¡£´óÁ¿NÔªËض¼ÊÇÓлúµª£¬±»½áºÏÓÚ°±»ùËá»òºËÜÕËá·Ö×ÓÖС£ ^Hd[+vAvR  
µØÇòÉϵĶ¯Ö²Îï¹²º¬µªÔ¼1.5¡Á1010t£¬¶øÿÄêͨ¹ýÏõ»¯Ï¸¾úÒÔÆø̬µªµÄÐÎʽÊͷŵ½´óÆøÖеĵª¾ÍÓÐ2¡Á108¡ª5¡Á108t¡£È«ÊÀ½çµª·Ê³§Ã¿ÄêÉú²úµÄ»¯·Ê½öº¬µªÔ¼108t£¬ËùÒÔ£¬Èç¹ûûÓÐÉúÎï¹Ìµª£¬ÉúÃüºÜ¿ì¾Í²»¸´´æÔÚÁË¡£ &Mh.PzO=b  
AIF ?>wgq  
1. ï§Í¨¹ý¹È°±Ëá¡ú¹È°±õ£°·±»½áºÏµ½ÓлúÎïÖÊÖС£ asWk]jjMG  
Ö÷ÒªÓÐÁ½²½·´Ó¦£º GkGiQf4hh  
¢ÅGlutamate+ATP¡ú¦Ã-glutamylphosphate+ADP O<u=Vz3c~0  
¢Æ¦Ã-Glutamyl phosphate+NH4+¡úglutamine+Pi+H+ /6x&%G:m#  
×ܽ᣺ !fh (k  
Glutamyl+NH4++ATP¡úglutamine+ ADP+Pi+H+ tOwn M1 :(  
Òò´Ë£¬¹È°±õ£°·ºÏ³ÉøÊǵª´úлÖеÄÖ÷Òªµ÷¿Øλµã¡£ 3I)~;>meo  
Ôڴ󳦸˾úÖУ¬GSÓÉ12¸öÏàͬµÄÑÇ»ù£¨50kDa£©¾ÛºÏ¶ø³É£¬Æä»îÐÔ¼Èͨ¹ý¹¹Ïó±ä»¯£¬Ò²ÄÜͨ¹ý¹²¼ÛÐÞÊεķ½Ê½µÃµ½µ÷½Ú¡£Alanine£¬GlycineºÍÆäËüÖÁÉÙ6ÖÖgln´úл²úÎﶼÊÇGS»îÐԵı乹ÒÖÖƼÁ£¬Ã¿¸öÒÖÖƼÁ¶¼Ö»Óв¿·ÖÒÖÖÆ×÷Óᣳý±ä¹¹ÒÖÖÆÖ®Í⣬GS»îÐÔ»¹Êܹ²¼ÛÐÞÊε÷½Ú¡£µ±µÚ397λÀÒ°±Ëá±»ÏÙÜÕ»¯ºó£¨¼ÓÉÏAMP£©£¬¸Ãø¸üÈÝÒ×Êܱ乹ÒÖÖƼÁµÄ·´À¡µ÷½Ú¡£ coP->&(@U#  
2.°±»ùËáµÄÉúÎïºÏ³É 0PzSp ]  
¸ßµÈ¶¯Îï²»ÄܺϳɴóÔ¼Ò»°ë°±»ùËᣬֻÄÜ´ÓʳÎïÖÐÖ±½Ó»ñÈ¡ÕâЩ±ØÐè°±»ùËᣨEssential£©¡£ Xs03..S  
±í18-1 ÈËÌå±ØÐè°±»ùËá(*.²¸ÈéÆÚÖÁÓ׶ùÆÚ±ØÐè) +! 1_Mt6  
±í22-1 °±»ùËáºÏ³ÉµÄÁùÌõÖ÷Ҫ;¾¶ i7x&[b  
3.°±»ùËáÍÑôÈ»ù»¯ºóÉú³ÉÓлú°·¡£Ðí¶àÖØÒªµÄÉñ¾­µÝÖʶ¼ÊÇ°·»òÆä´ÎÉú´úл²úÎï¡£Tyrosine½µ½â²úÎïÓÐdopamine£¨¶à°Í°·£©£¬epinephrine£¨ÉöÉÏÏÙËØ£©£¬norepinephrine£¬Í³³ÆΪCatecholamines£¨¶ù²è·Ó°·£©¡£ u$ts>Q;5  
4.¾«°±Ëá½µ½â²úÉúNO¨B(Nitric Oxide)¡£ M xTJgY  
±¾ÊÀ¼Í80Äê´ú£¬¿Æѧ¼Ò·¢ÏÖNOÊÇÈËÌåÄÚÖØÒªµÄÐźŷÖ×Ó£¬Ëü²ÎÓëÉñ¾­´«µÝ¡¢ÄýѪºÍѪѹµ÷¿ØµÈһϵÁÐÉúÀí·´Ó¦¡£ËäÈ»ËüÊÇÆøÌ壬¼«Ò×À©É¢£¬µ«ÓÉÓÚËüÊ®·Ö»îÔ¾£¬ÆäÀ©É¢°ë¾¶Ò»°ãÖ»ÓÐ1mm¡£ o9kJ90{D=  
 H.5 6  
Èý¡¢°±»ùËá¼°¹¦Äܵ°°×ÖʺϳɺóµÄÐÞÊÎ ,Py\Cp=Dw  
1.µ°°×Öʸոձ»ºÏ³Éʱ£¬¶¼ÒÔfMet£¨Ô­ºË£©»òMet£¨ÕæºË£©¿ªÊ¼£¬¶àëĺϳɺó£¬N¶ËµÄformyl group¡¢Met²Ð»ù£¬ÓÐʱ»¹°üÀ¨N´§¶à¸ö²Ð»ù»òC¶ËµÄ²Ð»ù¶¼»á±»Çгý¡£50%µÄÕæºËµ°°×ÖУ¬N-¶Ë²Ð»ùµÄ°±»ùËá»á±»N-ÒÒ»ù»¯¡£ |G j.E  
2.ÇгýÐźÅëÄ¡£Ðí¶àµ°°×Öʶ¼´øÓÐ15-30¸ö²Ð»ùµÄsignal peptides£¬¸ºÔðÖ¸µ¼µ°°×ÖÊÔÚϸ°ûÖеľ«È·¶¨Î»¡£ _c5@)I~  
3.Ìض¨°±»ùËáµÄÐÞÊΡ£ B=SA +{o  
4.°±»ùËáµÄÌÇÜÕ»¯ OC! {8MR  
5.°±»ùËáµÄÒìÎìÏ©»¯£¨Addition of Isoprenyl Groups£© b 74 !Zw  
6.ÓÐЩµ°°×ÖÊ»¹ÒªÓ븨»ù(prosthetic groups)Ïà½áºÏ£» TWP@\ BQ  
Cytochrome CÖ»ÓÐÓëѪºìËØ£¨heme£©Ïà½áºÏ²ÅÓй¦ÄÜ¡£´ËÍ⣬Acetyl-CoAôÈ»¯Ã¸³£ÓëBiotin·Ö×ÓÏà½áºÏ¡£ÓÐЩµ°°×ÖʱØÐë¾­µ°°×øÇиîºó²ÅÓй¦ÄÜ¡£ÓÐЩµ°°×ÖÊÖ»ÓÐÔÚÐγɶþÁò¼üÖ®ºó²ÅÓй¦ÄÜ¡£ D  T5d]MU  
N,`@Q7  
ËÄ¡¢µ°°×ÖʵÄÔËÊäºÍ½µ½â [(X~C*VdxM  
1¡¢¾ø´ó²¿·Ö±»ÔËÈëERÄÚÇ»µÄµ°°×Öʶ¼´øÓÐÒ»¸öSignal peptide¡£¸ÃÐòÁг£³£Î»ÓÚµ°°×Öʵݱ»ùÄ©¶Ë£¬³¤¶ÈÒ»°ãÔÚ13-36¸ö²Ð»ùÖ®¼ä£¬ÓÐÈý¸öÌص㣺 £¨1£©Ò»°ã´øÓÐ10-15¸öÊèË®°±»ùË᣻ £¨2£©³£³£ÔÚ¿¿½ü¸ÃÐòÁÐN-¶ËÊèË®°±»ùËáÇøÉÏÓδøÓÐ1¸ö»òÊý¸ö´øÕýµçºÉµÄ°±»ùË᣻ £¨3£©ÔÚÆäC-Ä©¶Ë¿¿½üµ°°×øÇиîλµã´¦³£³£´øÓÐÊý¸ö¼«ÐÔ°±»ùËᣬÀëÇиîλµã×î½üµÄÄǸö°±»ùËáÍùÍù´øÓк̵ܶIJàÁ´£¨Ala»òGly£©¡£ ,Ag{-&  
Ñо¿·¢ÏÖ£¬ÐźÅëÄ°ÑRibosomeÇ£Òýµ½ERÉÏ¡£µ°°×ÖʺϳÉÖ®³õ£¬Ò»µ©ÐźÅëÄÐòÁеÄN¶Ë±©Â¶ÔÚºËÌÇÌåÍ⣬¸ÃÐòÁУ¨°üÀ¨ºËÌÇÌ壩¾ÍѸËÙÓëSRP£¨signal recognition particle£©Ïà½áºÏ£¬ÓÕ·¢SRPÓëGTPÏà½áºÏ£¬Í£Ö¹ÐÂÉúëĵĽøÒ»²½ÑÓÉ죨´ËʱÐÂÉúëÄÒ»°ã³¤Ô¼70¸ö²Ð»ù×óÓÒ£©¡£ 1[P}D~ nQ  
ÊÜλÓÚERÍâĤÉϵÄSRP-receptor¼°ribosome-receptorµÄÇ£Òý£¬Õâ¸ö¸´ºÏÎï£*****TP-SRP-ribosome-mRNA-ÐÂÉúëÄ£©Á¢¼´ÏòERÍâĤ¿¿Â££¬²¢Í¨¹ýpeptide transport complex½øÈëERÄÚÇ»¡£ \f,<\mJ#  
5.Rough ERÉϵĵ°°×Öʳ£³£Í¨¹ýÔËתÔØÌ彫¾­¹ýÐÞÊεĵ°°×ÖÊËÍÈë¸ß¶û»ùÌ壬ÔÙ·Ö±ðË͵½¸÷¸öÑÇϸ°ûλµã¡£ 5i br1zs  
6.µ°°×ÖÊÖеĺ˶¨Î»ÐòÁÐÒ»°ã²»±»Çгý¡£ 6IqPZ{g9K'  
µ°°×Öʵĺ˶¨Î»ÊÇͨ¹ý¶à¸öµ°°×µÄ¹²Í¬×÷ÓÃÀ´ÊµÏֵġ£Importin (¦Á,¦ÂÑÇ»ù)µÄ×÷ÓÃÓеãÏñSRPÊÜÌå¡£NLSµ°°×-Importin¸´ºÏÎïÍ£ÁôÔں˿×ÉÏ£¬²¢ÔÚRan-GTPaseµÄ×÷ÓÃÏÂͨ¹ýºË¿×¡£ [R]V4Hb  
ϸ¾úϸ°ûÄÚÒ²´æÔÚÀàËƵĵ°°×ÖÊÔËתϵͳ¡£ F|%PiC,,qO  
7¡¢µ°°×Öʽµ½âÊÇÒ»¸öÓÐÐòµÄ¹ý³Ì¡£ ,Yag! i>;  
Ôڴ󳦸˾úÖУ¬Ðí¶àµ°°×ÖʵĽµ½âÊÇͨ¹ýÒ»¸öÒÀÀµÓÚATPµÄµ°°×ø£¨³ÆΪLon£©À´ÊµÏֵġ£µ±Ï¸°ûÖдæÔÚÓдíÎó»ò°ëË¥Æں̵ܶĵ°°×ÖÊʱ£¬¸Ãµ°°×ø¾Í±»¼¤»î¡£Ã¿ÇгýÒ»¸öëļüÒªÏûºÄÁ½·Ö×ÓATP¡£ k>i88^kPV  
ÔÚÕæºËÉúÎïÖУ¬µ°°×ÖʵĽµ½âÐèÒªUbiquitin£¬Ò»¸öÓÐ76¸ö°±»ùËá²Ð»ù×é³É¼«Îª±£Êصĵ°°×²ÎÓë¡£ÓëUbiquitinÏàÁ¬µÄµ°°×½«±»Ë͵½Ò»¸öÒÀÀµÓÚATPµÄµ°°×Öʽµ½âϵͳ£¨Proteasome£¬Mr. 1¡Á106£©¡£ Q%CrB>|@  
³ÉÊì¶àëÄN-¶ËµÚÒ»¸ö²Ð»ù¶Ôµ°°×ÖʵÄÎȶ¨ÐÔÓÐÖØÒªÓ°Ïì ¡£ c |0p'EQ  
^-%'ItVO  
Îå¡¢DNA´úл  ?K-4T  
ÎÞÂÛÊÇÖ»º¬ÓÐÒ»¶ÔȾɫÌåµÄÔ­ºËϸ°û»¹ÊÇ´øÓжà¶ÔȾɫÌåµÄÕæºËϸ°û£¬Ö»ÓÐÕû¸ö»ùÒò×éµÃµ½ÁËÍêÕû׼ȷµÄ¸´ÖÆ£¬Ï¸°û·ÖÁѲÅÄÜ˳Àû·¢Éú¡£ËùÒÔ˵£¬DNA¸´ÖƵÄÆðʼ£¬±êÖ¾ÁËϸ°û½øÈëÒ»¸öеÄÖÜÆÚ¡£ *`a$6F7m4  
Ò»¡¢DNA¸´ÖÆ [8u9q.IZ  
¸ù¾Ý·´Ó¦½×¶ÎºÍËùÐèµÄ²»Í¬Ã¸À࣬DNAµÄ¸´Öƿɱ»·ÖΪÈý¸ö½×¶Î£¬¼´¸´ÖÆÆðʼ¡¢ÑÓÉìºÍÖÕÖ¹¡£Ã¿¸öDNA¸´ÖƵĶÀÁ¢µ¥Ôª±»³ÆΪ¸´ÖÆ×Ó£¨replicon£©£¬Ö÷Òª°üÀ¨¸´ÖÆÆðʼλµã£¨Origine of replication£©ºÍÖÕֹλµã£¨terminus£©¡£Ô­ºËÉúÎïµÄÕû¸öȾɫÌåÉÏÒ»°ãÖ»ÓÐÒ»¸ö¸´ÖÆÆðʼλµã¡£ PqspoH 0OI  
´ó³¦¸Ë¾úDNAµÄ¸´ÖÆÐèÒªÓÐ20ÖÖ×óÓÒµÄøºÍµ°°×ÖÊÒò×Ó²ÎÓ룬Õû¸öDNA¸´ÖÆ»úÆ÷±»³Æ֮ΪDNA replicase system»òreplisome¡£ ch# )XomN  
Helicase£¬ÈκÎDNAÔÚ±»¸´ÖÆÇ°¶¼±ØÐë½â¿ªË«Á´£¬Õâ¸ö¹ý³ÌÊÇÓÉhelicaseÀ´Íê³ÉµÄ£¬Ëü¿ÉÔÚATPµÄ×÷ÓÃϽ«DNAĸÁ´²»¶Ï½â¿ªÐγɵ¥Á´¡£ %[XP}L$  
Topoisomerase£¬Ö÷Òª¹¦ÄÜÊÇÏû³ýDNA½âÁ´¹ý³ÌÖÐËù²úÉúµÄŤÇúÁ¦¡£ /#9 P0@Y  
DNA½áºÏµ°°×£¬Ê¹Ð½âÁ´µÄDNA±£³ÖÎȶ¨½á¹¹¡£  l!1_~!{y  
Primases£¬ÎªDNA¸´ÖÆÌṩRNAÒýÎï¡£ y[J9"k(@  
DNA polymerases£¬ºÏ³ÉÐÂÉúDNAÁ´£¬ÇгýRNAÒýÎï¡£ lhM5a \  
DNA Ligases£¬Ê¹ÐÂÉúDNAÁ´ÉϵÄȱ¿Ú£¨3¡¯-OH, 5¡¯-p£©Éú³ÉÁ×Ëá¶þõ¥¼ü¡£ 2)BO@]n  
1. DNA¸´ÖƵÄÆðʼ (XK,g;RoEn  
´ó³¦¸Ë¾úÖеĸ´ÖÆÆðʼλµãÊÇOri C£¬È«³¤245Bp£¬¸ÃÐòÁÐÔÚËùÓÐϸ¾ú¸´ÖÆÆðʼλµãÖж¼ÊDZ£Êصġ£ F`KXG$  
DNA¸´ÖÆÆðʼÖеÄÖ÷Òª²½Öè &5}YTKe}|  
a. ´óÔ¼20¸ö×óÓÒµÄDnaAµ°°×Ê×ÏÈÓëOriCÖеÄ4¸ö9¼î»ùÖظ´ÇøÏà½áºÏ£» v hZXgp0X  
b. ʶ±ð²¢Ê¹3¸ö13¼î»ù´®ÁªÖظ´ÇøDNAÐγɿª»·½á¹¹£» 8{W l   
c. DnaBµ°°×ÔÚDnaCµÄ°ïÖúÏÂÓëδ½âÁ´ÐòÁнáºÏ¡£Ã¿Áù¸öDnaBµ°°×ÐγÉÒ»×é²¢ÓëÒ»ÌõDNAĸÁ´½áºÏ£¬¿ÉÔÚ²»Í¬·½ÏòͬʱÆðʼDNAµÄ¸´ÖÆ¡£µ±Ï¸°ûÖдæÔÚ×ã¹»µÄSSBºÍDNA gyraseʱ£¬DnaBµÄ½âÁ´Ð§Âʷdz£¸ß¡£ dr)*.<_+a(  
Õû¸öDNA¸´Öƹý³ÌÖУ¬Ö»Óи´ÖÆÆðʼÊÜϸ°ûÖÜÆÚµÄÑϸñµ÷¿Ø¡£ 4{>r_^8  
"Once in each cell cycle¡£" jd]L}%ax  
DNA¼×»ù»¯ÓëDNA¸´ÖÆÆðʼÃÜÇÐÏà¹Ø¡£OriCÖÐÓÐ11¸öGATC»ØÎĽṹ£¨Ò»°ã˵À´£¬256bp²ÅÓ¦ÓÐÒ»¸öGATCÖظ´£©¡£DNA×ÓÁ´±»ºÏ³Éºó£¬Ä¸Á´Á¢¼´±»¼×»ù»¯£¨³ÆΪhemimethylated£©¡£´Ëʱ£¬oriCÓëϸ°ûÔ­ÉúÖÊĤÏà½áºÏ¡£Ö»Óе±oriC±»´ÓĤÉÏÊͷųöÀ´£¬×ÓÁ´±»Dam¼×»ù»¯ºó£¬²ÅÄÜÓÐЧµØÓëDnaAµ°°×½áºÏ£¬ÆðʼÐÂÒ»ÂÖµÄDNA¸´ÖÆ¡£¸´ÖÆÆðʼ¿ÉÄÜ»¹ÊÜATPË®½â¹ý³Ìµ÷¿Ø£¬ÒòΪDnaAÖ»ÓÐÓëATPÏà½áºÏʱ²ÅÄÜÓëoriCÇøDNAÏà½áºÏ¡£ i59 }6u_f  
2. DNA×ÓÁ´µÄÑÓÉì 8B ,S_0!  
Ö÷Òª°üÀ¨Á½¸ö²»Í¬µ«Ï໥ÓÐÁªÏµµÄʼþ£¬¼´Ç°µ¼Á´ºÍÖͺóÁ´µÄºÏ³É¡£ÓÉDNA helicase½â¿ªË«ÂÝÐý£¬ÓÉÍØÆÓÒ칹øÏû³ýDNAÁ´ÉϵÄŤÇúÁ¦£¬SSB½áºÏʹDNAµ¥Á´Îȶ¨¡£ 0L;,\&*u  
Ç°µ¼Á´µÄºÏ³É£ºÓÉDnaG£¨primase£©ÔÚ¸´ÖÆÆðʼλµã¸½½üºÏ³ÉÒ»¸ö10-60 ntµÄRNAÒýÎȻºóÓÉpolII°ÑdNTP¼Óµ½¸ÃÒýÎïÉÏ¡£ LYAGpcG  
ÖͺóÁ´µÄºÏ³É£º²úÉúOkazaki fragments£¬Ïû³ýRNAÒýÎï²¢ÓÉDNA pol I²¹ÉÏÕâһС¶ÎDNAÐòÁУ¬ÓÉDNA Ligase°ÑÁ½¸öƬ¶ÎÏàÁ¬¡£ V 2Xv)  
3. DNAÁ´µÄÖÕÖ¹ U_jW5mgsG  
µ±×ÓÁ´ÑÓÉì´ïµ½terminus region£¨ter£¬´øÓжà¸ö20bpÐòÁУ©Ê±£¬DNA¸´ÖƾÍÖÕÖ¹ÁË¡£TerÓеãÏñÒ»¸öÏݾ®£¨trap£©£¬Ê¹¸´ÖƲæÖ»ÄܽøÈ룬²»ÄܳöÀ´¡£TerµÄ¹¦ÄÜÖ÷ÒªÊÇÓÉTer-Tus¸´ºÏÎter utilization substance£©À´Íê³ÉµÄ¡£ @l3&vt2=J  
4. ÕæºËϸ°ûDNAµÄ¸´ÖƱȴ󳦸˾ú¸ü¸´ÔÓ +:Xg7H*  
ÕæºËÉúÎïµÄorigin of replication±»³ÆΪARS-autonomously replicating sequences»òÕß±»³ÆΪreplicators¡£Yeast replicators³¤Ô¼150dp£¬Óжà¸ö±£ÊØÖظ´Çø£¬¹²ÓÐÔ¼500¸öreplicators·Ö²¼ÓÚ½ÍĸµÄ17ÌõȾɫÌåÖС£ wmpQF<  
E2l" e?AN~  
¶þ¡¢DNAµÄËðÉËÐÞ¸´ F=&,=r' Q8  
1£® ´íÅäÐÞ¸´£¨mismatch Repair£© &%v*%{|j  
´íÅäÐÞ¸´¶ÔDNA¸´ÖÆÖÒʵÐԵűÏ×Á¦´ï102-103£¬DNA×ÓÁ´ÖеĴíÅ伸ºõÍêÈ«¶¼±»ÐÞÕý£¬³ä·Ö·´Ó³ÁËĸÁ´µÄÖØÒªÐÔ¡£  Z/Wf  
2. ¼î»ùÇгýÐÞ¸´£¨Base-Excision Repair£© RrLj5Jq  
DNA gylcosylasesÄÜÌØÒìÐÔʶ±ð³£¼ûµÄDNAËðÉË£¨Èç°ûà×ऻòÏÙàÑßÊÈ¥°±õ£»¯²úÎ²¢½«ÊÜË𺦼î»ùÇгý¡£È¥µô¼î»ùºóµÄºËÜÕËá±»³ÆΪAPλµã£¨apurinic or apyrimidinic£©¡£Ï¸°ûÖÐ×î³£¼ûµÄUracil Glycosylase¾ÍÄÜÌØÒìÐÔÇгýϸ°ûÖеÄÈ¥°±»ù°ûà×ड£ R;,5LS&*a  
3. ºËÜÕËáÇгýÐÞ¸´£¨nucleotide-excision repair£© 3N]ushMO  
µ±DNAÁ´ÉÏÏàӦλÖõĺËÜÕËá·¢ÉúËðÉË£¬µ¼ÖÂË«Á´Ö®¼äÎÞ·¨ÐγÉÇâ¼ü£¬ÓɺËÜÕËáÇгýÐÞ¸´ÏµÍ³¸ºÔð½øÐÐÐÞ¸´¡£ ^G qO>1U  
4.DNAµÄÖ±½ÓÐÞ¸´£¨Direct repair£© c}v8j2{  
uf]wX(*<k  
Èý¡¢DNAµÄת×ù f2tCB1[D+  
DNAµÄת×ù£¬»ò³ÆÒÆ루transposition£©£¬ÊÇÓÉ¿ÉÒÆλÒò×Ó£¨transposable element£©½éµ¼µÄÒÅ´«ÎïÖÊÖØÅÅÏÖÏó¡£ÒѾ­·¢ÏÖ"ת×ù"ÕâÒ»ÃüÃû²¢²»Ê®·Ö׼ȷ£¬ÒòΪÔÚת×ù¹ý³ÌÖУ¬¿ÉÒÆλÒò×ÓµÄÒ»¸ö¿½±´³£³£ÁôÔÚÔ­À´Î»ÖÃÉÏ£¬ÔÚÐÂλµãÉϳöÏֵĽö½öÊÇ¿½±´¡£Òò´Ë£¬×ª×ùÓбðÓÚͬԴÖØ×飬ËüÒÀÀµÓÚDNAµÄ¸´ÖÆ¡£ A99;bf}"  
1£® ת×ù×ӵķÖÀàºÍ½á¹¹ÌØÕ÷ _e8Gt6>  
a. ¼òµ¥×ª×ù×Ó &n] v  
ת×ù×Ó£¨transposon£¬Tn£©ÊÇ´æÔÚÓÚȾɫÌåDNAÉÏ¿É×ÔÖ÷¸´ÖƺÍÒÆλµÄ»ù±¾µ¥Î»¡£ "z6p= B"?3  
×î¼òµ¥µÄת×ù×Ó²»º¬ÓÐÈκÎËÞÖ÷»ùÒò¶ø³£±»³ÆΪ²åÈëÐòÁУ¨insertion sequence£¬IS£©£¬ËüÃÇÊÇϸ¾úȾɫÌå»òÖÊÁ£DNAµÄÕý³£×é³É²¿·Ö¡£Ò»¸öϸ¾úϸ°û³£´øÓÐÉÙÓÚ10¸öISÐòÁС£×ª×ù×Ó³£³£±»¶¨Î»µ½Ìض¨µÄ»ùÒòÖУ¬Ôì³É¸Ã»ùÒòÍ»±ä¡£ISÐòÁж¼ÊÇ¿ÉÒÔ¶ÀÁ¢´æÔڵĵ¥Ôª£¬´øÓн鵼×ÔÉíÒƶ¯µÄµ°°×¡£ dm[JDVv|  
b.¸´ºÏʽת×ù×Ó£¨composite transposon£©ÊÇÒ»Àà´øÓÐijЩ¿¹Ò©ÐÔ»ùÒò£¨»òÆäËûËÞÖ÷»ùÒò£©µÄת×ù×Ó£¬ÆäÁ½ÒíÍùÍùÊÇÁ½¸öÏàͬ»ò¸ß¶ÈͬԴµÄISÐòÁУ¬±íÃ÷ISÐòÁвåÈ뵽ij¸ö¹¦ÄÜ»ùÒòÁ½¶Ëʱ¾Í¿ÉÄܲúÉú¸´ºÏת×ù×Ó¡£Ò»µ©Ðγɸ´ºÏת×ù×Ó£¬ISÐòÁоͲ»ÄÜÔÙµ¥¶ÀÒƶ¯£¬ÒòΪËüÃǵŦÄܱ»ÐÞÊÎÁË£¬Ö»ÄÜ×÷Ϊ¸´ºÏÌåÒƶ¯¡£ nzO -\`40  
2¡¢×ª×ù×÷ÓõĻúÖÆ Li8/GoJW-T  
ת×ùʱ·¢ÉúµÄ²åÈë×÷ÓÃÓÐÒ»¸öÆÕ±éµÄÌØÕ÷£¬ÄǾÍÊÇÊÜÌå·Ö×ÓÖÐÓÐÒ»¶ÎºÜ¶ÌµÄ£¨3-12bp£©¡¢±»³ÆΪ°ÐÐòÁеÄDNA»á±»¸´ÖÆ£¬Ê¹²åÈëµÄת×ù×ÓλÓÚÁ½¸öÖظ´µÄ°ÐÐòÁÐÖ®¼ä¡£²»Í¬×ª×ù×ӵİÐÐòÁг¤¶È²»Í¬£¬µ«¶ÔÓÚÒ»¸öÌض¨µÄת×ù×ÓÀ´Ëµ£¬ËüËù¸´ÖƵİÐÐòÁг¤¶È¶¼ÊÇÒ»ÑùµÄ£¬ÈçIS1Á½Òí×ÜÓÐ9¸ö¼î»ù¶ÔµÄ°ÐÐòÁУ¬¶øTn3Á½¶Ë×ÜÓÐ5bpµÄ°ÐÐòÁС£ d~.hp  
ת×ù¿É±»·ÖΪ¸´ÖÆÐԺͷǸ´ÖÆÐÔÁ½´óÀà¡£ÔÚ¸´ÖÆÐÔת×ùÖУ¬ËùÒƶ¯ºÍתλµÄÊÇԭת×ù×ӵĿ½±´¡£×ª×ùø£¨transposase£©ºÍ½âÀëø£¨resolvase£©·Ö±ð×÷ÓÃÓÚԭʼת×ù×Ӻ͸´ÖÆת×ù×Ó¡£TnAÀàת×ùÖ÷ÒªÊÇÕâÖÖÐÎʽ¡£ÔڷǸ´ÖÆÐÔת×ùÖУ¬Ô­Ê¼×ª×ù×Ó×÷Ϊһ¸ö¿ÉÒƶ¯µÄʵÌåÖ±½Ó±»ÒÆ룬ISÐòÁС¢Mu¼°Tn5µÈ¶¼ÒÔÕâÖÖ·½Ê½½øÐÐת×ù¡£ p  Dg!Cs  
3.ת×ù×÷ÓõÄÒÅ´«Ñ§Ð§Ó¦ x`2dN/wDhf  
¢Ù ת×ùÒýÆð²åÈëÍ»±ä;¢Ú ת×ù²úÉúеĻùÒò;¢Û ת×ù²úÉúµÄȾɫÌå»û±ä;¢Ü ת×ùÒýÆðµÄÉúÎï½ø»¯. 8bw, dBN  
vh|m[p  
Áù¡¢RNA´úл j!L7r'AV5  
³ýÁËijЩRNA²¡¶¾Ö®Í⣬ËùÓÐRNA·Ö×Ó¶¼À´×ÔÓÚDNA¡£»ùÒò×éDNAͨ¹ýÒ»¸ö±»³ÆΪת¼µÄ¹ý³Ì°ÑÖü´æÔÚË«Á´DNA·Ö×ÓÖеÄÒÅ´«ÐÅϢת»»µ½ÓëÄ£°åDNAÁ´Ï໥²¹µÄRNAµ¥Á´ÉÏ¡£ xn=mS!"1Zo  
mRNA£¬±àÂëÁËÒ»¸ö»ò¶à¸öµ°°×ÖÊÐòÁУ»tRNA£¬°ÑmRNAÉϵÄÒÅ´«ÐÅÏ¢±äΪ¶àëÄÖеݱ»ùËáÐÅÏ¢£»rRNA£¬ÊǺϳɵ°°×ÖʵŤ³§ºËÌÇÌåÖеÄÖ÷Òª³É·Ý¡£ gjiS+N[  
1£® ÒÀÀµÓÚDNAµÄRNAºÏ³É 0LGHSDb  
´ÓDNAºÏ³É·´Ó¦µÄ»¯Ñ§±¾ÖÊ¡¢¼«ÐÔºÍÄ£°åµÄʹÓÃÕâÈý·½ÃæÀ´Ëµ£¬×ªÂ¼Ó븴ÖÆÊÇÏàͬµÄ¡£µ«ÊÇ£¬Ò²´æÔÚÈý¸öÖ÷Òª²»Í¬µã£º g \+!+!"~  
A£® ת¼Öв»ÐèÒªRNAÒýÎ hQ)?LPUB  
B£®×ªÂ¼·´Ó¦Ò»°ãÖ»ÓÃһС¶ÎDNA×öÄ£°å£» XYV`[,^h&  
C£®ÔÚת¼Çø£¬Ò»°ã¶¼Ö»ÓÐÒ»ÌõDNAÁ´¿ÉÒÔ×÷Ϊģ°å¡£ 3]NKAPY  
2.RNAºÏ³ÉµÄÖÕÖ¹ u3cg&lEgT  
Ò»µ©RNA¾ÛºÏøÆô¶¯ÁË»ùÒòת¼£¬Ëü¾Í»áÑØ×ÅÄ£°å5¡¯¡ú3¡¯·½Ïò²»Í£µØÒƶ¯£¬ºÏ³ÉRNAÁ´£¬Ö±µ½Óöµ½ÖÕÖ¹ÐźÅʱ²ÅÊÍ·ÅÐÂÉúµÄRNAÁ´£¬²¢ÓëÄ£°åDNAÍÑÀë¡£ Us6~7L00  
Ñо¿RNAÁ´ÖÕֹʱÓöµ½×î³£¼ûµÄÎÊÌâÊÇ3¡¯¶ËºËÜÕËáµÄ¶¨Î»£¬ÒòΪ»îϸ°ûÄÚ²¿¸ù¾ÝÖÕÖ¹ÐźÅÕýÈ·ÖÕÖ¹µÄRNAÓëÒ»¸ö¾­¹ý¼ô½ÓµÄRNAÔÚ3¡¯¶ËûÓÐÁ½Ñù£¬¶¼ÊÇ-OH»ùÍÅ¡£Ä£°åDNAÉ϶¼ÓÐÖÕֹת¼µÄÌØÊâÐźÅ--ÖÕÖ¹×Ó£¬Ã¿¸ö»ùÒò»ò²Ù×Ý×Ó¶¼ÓÐÒ»¸öÆô¶¯×Ó£¬Ò»¸öÖÕÖ¹×Ó¡£ÔÚÐÂÉúRNAÖгöÏÖ·¢¿¨Ê½½á¹¹»áµ¼ÖÂRNA¾ÛºÏøµÄÔÝÍ££¬ÆÆ»µRNA-DNAÔÓºÏÁ´5¡¯¶ËµÄÕý³£½á¹¹¡£¹Ñ¾ÛUµÄ´æÔÚʹÔÓºÏÁ´µÄ3¡¯¶Ë²¿·Ö³öÏÖ²»Îȶ¨µÄrU£®dAÇøÓò¡£ uI)z4Z  
a. ÒÀÀµÓÚ¦ÑÒò×ÓµÄÖÕÖ¹ #BEXj<m+J  
¦ÑÒò×ÓÊÇÒ»¸öÏà¶Ô·Ö×ÓÖÊÁ¿Îª2.0¡Á105µÄÁù¾ÛÌåµ°°×£¬ËüÄÜË®½â¸÷ÖÖºËÜÕÈýÁ×Ëᣬʵ¼ÊÉÏÊÇÒ»ÖÖNTPø¡£ÓÉÓÚ´ß»¯ÁËNTPµÄË®½â£¬¦ÑÒò×ÓÄÜ´ÙʹÐÂÉúµÄRNAÁ´´ÓÈýԪת¼¸´ºÏÎïÖнâÀë³öÀ´£¬´Ó¶øÖÕֹת¼¡£ O|v 8.3[cT  
ÓÐÈËÈÏΪ£¬ÔÚRNAºÏ³ÉÆðʼÒԺ󣬦ÑÒò×Ó¼´¸½×ÅÔÚÐÂÉúµÄRNAÁ´ÉÏ£¬¿¿ATPË®½â²úÉúµÄÄÜÁ¿£¬ÑØ×Å5¡¯¡ú3¡¯·½Ïò³¯RNA¾ÛºÏøÒƶ¯£¬µ½´ïRNAµÄ3¡¯-OH¶ËºóÈ¡´úÁËÔÝÍ£ÔÚÖÕֹλµãÉϵÄRNA¾ÛºÏø£¬²¢´ÓÄ£°åºÍøÉÏÊÍ·ÅRNA£¬Íê³Éת¼¹ý³Ì¡£ÖÕÖ¹¹ý³ÌÐèÒªÏûºÄÄÜÁ¿£¬ËùÒÔ£¬¦ÑÒò×Ó¾ßÓÐÖÕֹת¼ºÍºËÜÕÈýÁ×ËáøÁ½ÖÖ¹¦ÄÜ¡£ %h_N%B$7c1  
b¡¢²»ÒÀÀµÓÚ¦Ñ Òò×ÓµÄÖÕÖ¹ < A`srmS?  
ÈôÖÕÖ¹µãÉÏÓδæÔÚÒ»¸ö¸»º¬GC¼î»ùµÄ¶þÖضԳÆÇø£¬ÓÉÕâ¶ÎDNAת¼²úÉúµÄRNAÈÝÒ×Ðγɷ¢¿¨Ê½½á¹¹£»ÔÚÖÕÖ¹µãÇ°ÃæÓÐÒ»¶ÎÓÉ4-8¸öA×é³ÉµÄÐòÁУ¬µ¼ÖÂת¼²úÎïµÄ3¡®¶ËΪ¹Ñ¾ÛU¡£ÕâÁ½ÖֽṹÌØÕ÷µÄ´æÔÚͬÑù¾ö¶¨ÁËת¼µÄÖÕÖ¹¡£ *yg`V,C  
ÔÚÐÂÉúRNAÖгöÏÖ·¢¿¨Ê½½á¹¹»áµ¼ÖÂRNA¾ÛºÏøµÄÔÝÍ££¬ÆÆ»µRNA-DNAÔÓºÏÁ´5¡¯¶ËµÄÕý³£½á¹¹¡£¹Ñ¾ÛUµÄ´æÔÚʹÔÓºÏÁ´µÄ3¡¯¶Ë²¿·Ö³öÏÖ²»Îȶ¨µÄrU£®dAÇøÓò¡£ hZ>1n&[ @  
3.RNA¾ÛºÏøII¼°×ªÂ¼Òò×ÓÔÚÆô¶¯×ÓÉϵÄ×°Åä x {R j2~KC  
TF¢òH»¹²ÎÓëDNAµÄËðÉËÐÞ¸´¡£µ±RNA pol¢òת¼¹ý³ÌÖÐÅöµ½ÊÜËðÉ˵ĺËÜÕËáʱ£¬TF¢òHÄܼ°Ê±Æô¶¯ºËÜÕËáÇгýÐÞ¸´ÏµÍ³£¬½«ËðÉËÐÞ¸´¡£ 3;//o<  
Actinomycin DºÍAcridine×è¶ÏRNAÁ´µÄÑÓÉì gxDyCL$h3  
4.RNAµÄ¼Ó¹¤³ÉÊì =m;cy0))  
ËùÒÔ£¬RNA¼Ó¹¤³ÉÊìÖ÷Òª°üÀ¨£º5¡¯¼Óñ×ӽṹ£»3¡¯¼Ó¶à¾ÛA£»ÇгýÄÚº¬×Ó ¡£ 7&dF=/:X@  
ÔÚGroup IÄÚº¬×ÓÇгýÌåϵÖУ¬ÄñÜÕ»òÄñÜÕËáµÄ3¡¯-OH ×÷ΪÇ׺˻ùÍÅÏòIntron 5¡¯µÄÁ×Ëá¶þõ¥¼ü·¢Æð½ø¹¥¡£ 3cH^ ,F  
Group IIÄÚº¬×ÓÇгýÌåϵ vQ5rhRG)E  
ºËÄÚmRNAԭʼת¼²úÎïµÄ¼ô¼­·½Ê½¿ÉÄÜÊÇ×î³£¼ûµÄ¡£ÔÚÕâһģʽÖУ¬RNAµÄ¼ô¼­ÐèÒªÌØÒìÐÔRNA-protein-¸´ºÏÎïsmall nuclear rebonucleoproteins£¨snRNP£©ºÍsmall nuclear RNAs£¨snRNAs£©¡£ÒѾ­·¢ÏÖÖÁÉÙÓÐ5ÖÖsnRNAs--U1£¬U2£¬U4£¬U5£¬U6¡£
ÆÀ¼ÛÒ»ÏÂÄãä¯ÀÀ´ËÌû×ӵĸÐÊÜ

¾«²Ê

¸Ð¶¯

¸ãЦ

¿ªÐÄ

·ßÅ­

ÎÞÁÄ

¹àË®

  
¼¶±ð: ³õ¼¶²©ÓÑ
ÏÔʾÓû§ÐÅÏ¢ 
ɳ·¢  ·¢±íÓÚ: 2009-09-08   
Â¥Ö÷ÓÐWord¸ñʽµÄÂ𣬸øÎÒ·¢Ò»·Ý°É£¬Ê®·Ö¸Ðл°¡£¡ JPe<qf-  
hungerlee_01@hotmail.com
¼¶±ð: ³õ¼¶²©ÓÑ
ÏÔʾÓû§ÐÅÏ¢ 
°åµÊ  ·¢±íÓÚ: 2009-09-12   
¶¥Ò»ÏÂ
¼¶±ð: Öм¶²©ÓÑ
ÏÔʾÓû§ÐÅÏ¢ 
µØ°å  ·¢±íÓÚ: 2009-09-13   
³¤¼ûʶÁË
¼¶±ð: Öм¶²©ÓÑ
ÏÔʾÓû§ÐÅÏ¢ 
µØÏÂÊÒ  ·¢±íÓÚ: 2010-06-26   
»Ø Â¥Ö÷(malin.1028) µÄÌû×Ó
лл¥Ö÷
¼¶±ð: ³õ¼¶²©ÓÑ
ÏÔʾÓû§ÐÅÏ¢ 
5Â¥  ·¢±íÓÚ: 2010-06-26   
ллÁË
ÃèÊö
¿ìËٻظ´

ÑéÖ¤ÎÊÌâ:
Ãâ·Ñ¿¼²©ÍøÍøÖ·ÊÇʲô? ÕýÈ·´ð°¸:freekaobo.com
°´"Ctrl+Enter"Ö±½ÓÌá½»